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ABSTRACT
A Comprehensive Comparison of Teratogenic Compound Known
to Induce Neural Tube Defects in the Chicken Embryo
Micah Marie Ross
Department of Physiology and Developmental Biology, BYU
Doctor of Philosophy
One of the first embryonic structures generated during early human development is the
neural tube. The embryonic process of neurulation, including neural tube closure, is necessary
for proper brain and spinal cord development, whereas improper closure leads to neural tube
defects including anencephaly, spina bifida, and craniorachischisis. The mechanism by which
these defects occur is unknown, but some evidence suggest that redox disruption may play a role.
Cellular redox state is important in regulating key processes during neural tube closure, including
differentiation, proliferation, gene expression, and apoptosis. This study aims to determine
whether redox potential shifts and these key processes are affected similarly or differentially
after treatment with three neural tube defect-inducing developmental toxicants: ceramide (C2),
valproic acid (VPA), and fumonisin (FB1).
Using the P19 cell model of neurogenesis, in both undifferentiated and terminally
differentiated cells, we analyzed glutathione (GSH) redox (Eh) potential to evaluate the effect of
each toxicant over time. We show that in C2 and VPA treated cultures an oxidizing shift occurs,
but interestingly, FB1 treatment results in a reducing shift in embryonic GSH Eh as compared to
untreated cultures. Using the chick embryo model, comparable redox shifts were observed as
were seen in P19 cells, supporting similarity between the models. To better understand how
differential shifts in the redox state can result in similar defects, we then examined potential
variances in neuronal differentiation and cellular proliferation, survival, metabolism, adhesion,
and gene expression under each treatment. We report changes to cellular and embryonic
endpoints that support dysmorphogenesis, likely the result of oxidizing or reducing stress that
altered redox state.
These results support the need for broad comparative analyses such as this to determine
whether toxicants that cause the same types of defects, whether NTDs or others, act through
similar or different mechanisms. This can better inform preventative measures used to reduce
the risk and occurrence of birth defects.

Key Words: ceramide, fumonisin b1, valproic acid, neural tube defects, teratogen, maternal
obesity, birth defects, oxidative stress, chicken embryo
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CHAPTER 1: Introduction
Neural Tube Closure and Defects
During the initial stages of development, the embryo begins as a flat sheet of cells (Figure
1.1 A). Intracellular signaling within this primitive tissue initiates morphological changes,
leading to bilateral elevation and bending of the left and right sides of this sheet, parallel to the
notochord, forming the neural groove and neural folds (Figure 1.1 B). These folds will initially
meet at the dorsal side of the future hindbrain of the developing embryo and adhere together.
Subsequent adhesion extends both anteriorly and posteriorly along the axis of the embryo,
resulting in an enclosed tube by day 28 of development (Figure 1.1 C). This early structure,
known as the neural tube (NT), gives rise to the brain and spinal cord of the embryo. If the
neural folds fail to rise, bend, or adhere at any point along the axis during this process, the
resulting opening gives rise to a neural tube defect (NTD; Figure 1.1 D).
Neural tube defects (NTDs), the second most common among birth defects, reportedly
affect 0.03-19.94/1000 pregnancies worldwide depending on location and reporting methods
(1991; Mitchell, 2005; Copp et al., 2013; Li et al., 2016; Zaganjor et al., 2016). One recent
review indicated that rates vary significantly, reporting ranges in African regions from 5.275.4/10000, in European countries from 1.3-39.5/10000 births, and in the Americas from 1.427.9/10000 (Bhandari and Thada, 2020). The type and severity of NTDs depends upon the
location and extent of the defect (Figure 1.2). Defects, defined by the location along the
anterior-posterior axis, include cranial, caudal, and complete NTDs. Cranial NTDs include
anencephaly (Figure 1.2 A) and encephalocele (Figure 1.2 B). Anencephaly results in partial or
complete failure of brain and skull development, occurring in 1/4,600 births in the United States
each year (Mai et al., 2019). Nearly all babies affected by anencephaly die in utero or shortly
1

Figure 1.1: Neural Tube Closure.
(A) The early embryo begins as a flat sheet of cells. The ectoderm of the embryo is divided
into three cell types: neural ectoderm (green), neural crest progenitors (white), and non-neural
ectoderm (yellow). Ventral to the embryo is the notochord (dark blue circle), a key signaling
center in early development. (B) During neurulation, mechanical forces a) drive lateral cells
toward the midline of the embryo (yellow and white arrows) and b) force cells dorsally near
the midline (green arrows). (C) Final stages of neurulation require dissociation and
subsequent adhesion of neural (green) and non-neural (yellow) cells to form the neural tube
(green) and overlying ectoderm (yellow). Neural crest cells migrate ventro-laterally (white).
(D) Failure of any mechanical changes, cell signaling, adhesion, or cell shape changes result
in an opening in the neural tube.
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after birth (Bakaniene et al., 2016). Encephalocele is a rarer defect, affecting 1/10,500 babies in
the United States annually (Mai et al., 2019). Unlike anencephaly, encephalocele is an enclosed,
sac-like protrusion, containing projections of the brain and membranes. This sac results from an
opening in the neural tube anywhere from the back of the skull to the nose of affected babies.
Surgical interventions are required to correct these defects, and long-term effects are dependent
upon the location and severity of the protrusion (Siffel et al., 2003).
Spinal NTDs are defined as open or closed dysraphism (failure of neural tube closure).
Closed NTDs are known as spina bifida occulta, or “hidden,” indicating that these defects are
subcutaneous or below the skin (Figure 1.2 C). The vertebrae, most commonly S1, S2 or both,
fail to form completely around the spinal cord, and generally cause no physical problems for the
affected individual. Spina bifida occulta may go undetected in 10-20% of the general
population, except for a tuft of hair at the base of the spinal cord in some cases. Open
dysraphism defects are more detrimental to infant health and mortality, and include myelocele,
meningocele, and myelomeningocele (Figure 1.2 D). Myelocele is exposed spinal tissue without
skin or meninges, the membranes that enclose the spinal cord and brain, at an opening at the base
of the back. In meningocele, the meninges protrude through the vertebrae and skin in a spinal
fluid filled sac. Infants born with meningocele may exhibit no symptoms, experience bladder and
bowel dysfunction, or display lower-limb paralysis. Myelomeningocele is a compounded defect
wherein the spinal fluid-filled sac at the base of the spine contains nerves and part of the spinal
cord. Myelomeningocele is the most severe type of open NTDs, resulting in babies who suffer
from mild to severe disabilities throughout their lives, including incontinence and partial or
complete paralysis (Bakaniene et al., 2016). Chiari II malformation of the hindbrain and
resulting
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Figure 1.2: Types of Neural Tube Defects in Infants.
(A) Anencephaly. (B) Encephaloceole. (C) Spina bifida occulta. (D) Open spina bifida. (E)
Craniorachischisis.
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hydrocephalus are associated with nearly 90% of open spinal NTDs (van Gool et al., 2018), often
resulting in additional surgeries and health concerns for affected children and adults.
In some rare cases embryos may develop craniorachischisis, a complete failure of
neural tube closure (Figure 1.2 E). Survival is impossible in cases of craniorachischisis, and
medical termination is recommended.
Maternal Obesity
Maternal obesity has increased more than 70% in the last decade (Rasmussen et al., 2008;
Jarvie and Ramsay, 2010). From 1980-2013, the number of adult, child-bearing women who
were overweight, increased nearly 18% to 38% (Ng et al., 2014). An elevated BMI during
pregnancy puts overweight and obese mothers at greater risk for pregnancy-related disorders
such as hypertension, preeclampsia, and gestational diabetes (Chen et al., 2020). Obesity is a comorbidity that is associated with a 2-fold increased risk for the development of NTDs
(Rasmussen et al., 2008; Huda et al., 2010). Type 2 diabetes mellitus (T2DM) is another
metabolic pathology linked to obesity and can increase the risk of NTDs in offspring by 2-fold
(Ray et al., 2007). Hyperglycemia, a condition arising from insulin resistance present in T2DM
and often obesity, has been studied extensively and is known to generate oxidative stress and
reduced expression of Pax3, a transcription factor found to induce ubiquitination and degradation
of p53 in the neural tube (Chappell et al., 2009; Wang et al., 2011). While insulin resistance and
hyperglycemic conditions are often associated with obesity, it is important to note that multiple
studies have shown that the effects of obesity and diabetes both independently and
synergistically affect fetal development (Bo et al., 2003; Simmons, 2011; Racusin et al., 2012).
Therefore, other biological factors that play a role in metabolic syndrome, including elevated
free fatty acids and inflammatory cytokines as well as altered hormone profiles, must be
5

investigated. Studying the ceramide axis and its role in NTD formation is one important area that
needs further investigation.
Environmental Causation of Embryo Defects
Environmental factors have been a central focus of NTD research due to the potential to
improve fetal outcomes through intervention. The maternal environment is critical during fetal
development; obesity, cigarette use, diabetes, hyperthermia and stress have all shown to have
negative effects on fetal growth, health, and mortality (Qiu et al., 2013; Alexander et al., 2015;
Gaillard, 2015; Ross et al., 2015). Recent years have revealed maternal diet influences
embryonic development. For example, a cluster of infants were born with NTDs in Cameron
County, Texas between 1990-1991. In one alarming 36-hour period, 3 anencephalic infants were
delivered in one hospital, with 3 additional cases over the next 6 weeks. Overall, the rate of
NTDs along the Texas-Mexico border increased to 2.7/1000 live births compared to the normal
rate of 0.2/1000 at that time in the United States (Missmer et al., 2006; Seidahmed et al.,
2014). As health officials investigated the potential causes for this increase in NTDs, they
discovered a link between this localized human outbreak and a nationwide epidemic of equine
leukoencephalomalacia (ELEM) just one year prior. Scientists tied the ELEM outbreak to a
mycotoxin produced by a common corn mold known as fumonisin (Missmer et al., 2006;
Reisinger et al., 2016). While corn was removed as a common horse feed, humans continued to
consume the crop. Studies showed higher than normal fumonisin concentrations in the corn
meal consumed by women in this area, suggesting a causative link between fumonisin B1 (FB1),
a mycotoxin produced by the Fusarium verticillioides mold, intake and NTDs (Hendricks, 1999;
Missmer et al., 2006; Voss et al., 2006). Maternal FB1 exposure, most commonly associated
with consumption of contaminated masa and rice, also induces NTDs in mouse models,
6

suggesting vertebrate neuronal development and health are affected by FB1 (Gelineau-van Waes
et al., 2009; Liao et al., 2014). It is unclear whether folate supplementation can rescue embryos
from FB1-induced defects.
Antiepileptic Pharmaceutical Associated Neural Tube Defects
More than 500,000 women of child-bearing age in the United States have epilepsy, a
disorder in which she experiences recurring, unprovoked seizures (Hirtz et al., 2007). Epilepsy
carries risks for several pregnancy-related complications, including preeclampsia, pregnancyinduced hypertension, bleeding complications, preterm delivery, and spontaneous abortions
(Harden et al., 2009). As such, women who are currently prescribed an antiepileptic medication
(AEM), are encouraged to continue their regimen throughout their pregnancy. One such AEM is
valproic acid (VPA), a short-chain fatty acid and histone deacetylase inhibitor that acts as a
broad-spectrum anticonvulsant (Gurvich et al., 2005). Valproic acid has been approved to treat
bipolar and other psychiatric disorders including schizophrenia and personality disorder. In fact,
a study conducted from 2003-2007 found that more women have been prescribed AEMs for
psychiatric disorders than those prescribed for epilepsy (Bobo et al., 2012). The number of
women of child-bearing age who have been prescribed VPA has increased dramatically in recent
decades (Lloyd, 2013; Atturu and Odelola, 2015). A correlation between AEMs and an
increased risk (2-3x) for birth defects was first reported in 1968 (Meadow, 1968; Tomson and
Battino, 2009; Palac and Meador, 2011). Valproic acid carries the greatest risk of all antiepileptic medications for NTDs in offspring (Meador et al., 2008), with a dose-dependent risk for
other defects as well, including impaired cognitive development (Bromley et al., 2010; Palac and
Meador, 2011; Pennell et al., 2012). While the underlying mechanism wherein VPA induces
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NTDs remains unknown, there is good evidence pointing to oxidative stress, a focus here with
data presented later.
Genetics in Neural Tube Defects
The genetic complexity of the events leading to NT closure is vast. Women who have
had an affected pregnancy are 2-5% (50-fold greater risk) more likely to have a subsequent NTD
pregnancy (Copp et al., 2013). Several identified genetic factors contribute to NTDs in animals
(Wilde et al., 2014), including mutations in ciliary signaling pathway, planar cell polarity
pathway (PCP), cellular division and differentiation, NT patterning, cellular motility and cell
adhesion components. Most of these genes have been identified in mouse mutants, while human
genetic screening has been of interest in recent years. Additionally, epigenome analysis has
revealed several mutations in acetylase, deacetylase, methylase, and demethylase proteins, as
well as nucleosome remodeling enzymes as being linked to NTDs (Wilde et al., 2014).
Developmental research has expanded the frontier of genetics to include the effects of geneenvironment interactions.
Glutathione Redox Potential and Embryonic Development
Reactive oxygen species (ROS), such as hydrogen peroxide, nitrogen oxide, super oxide
anion, and hydroxyl free radicals, are naturally occurring molecules with an unpaired electron,
generated via the reduction of oxygen. The mitochondria are the primary source of ROS
generation, as oxygen is reduced to generate ATP, accounting for up to 90% of all ROS
production (Balaban et al., 2005). During development, cells are constantly undergoing growth,
replication, migration, and differentiation, all of which require elevated levels of energy. This
results in greater levels of ROS as a by-product of increased metabolism in the embryo.
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Reactive oxygen species are often associated with deleterious outcomes such as lipid
peroxidation or protein and DNA damage. However, in recent years evidence indicates that
these low to moderate cellular levels of ROS may act as important signaling molecules that play
a role in cellular activities, including cell cycle and proliferation, differentiation, migration,
apoptosis, and antioxidant control (Allen and Tresini, 2000; Covarrubias et al., 2008; Albadri et
al., 2019). For example, hydrogen peroxide may act as signaling molecule to activate
angiogenesis (Gatenby and Gillies, 2004; Gao et al., 2007; Horak et al., 2010; Semenza and
Prabhakar, 2012), cell growth and proliferation (Papapostolou et al., 2014; Wang et al., 2017), or
cell survival (Groeger et al., 2009). If unregulated during development, these ROS can damage
DNA, macromolecules, and cell membranes.
Exposure to developmental toxicants can induce the generation of high levels of ROS
within a cell. Many environmental toxicants, such as xenoestrogens, pesticides, and heavy
metals induce oxidative stress and are associated with greater risk for negative developmental
outcomes. These toxicants have been associated with mitochondrial DNA damage/dysfunction,
resulting in prenatal outcomes (Stohs et al., 2001; Ooe et al., 2005; Moon et al., 2012).
Additionally, unhealthy practices by the mother may also lead to increased ROS generation and
exposure to her unborn child during early development; smoking, alcohol consumption, and drug
abuse have been linked to birth defects (Kovacic and Somanathan, 2006; Desrosiers et al., 2012).
Unhealthy eating and metabolic disorders, such as maternal diabetes and obesity, are also
associated with embryonic exposure to greater levels of ROS.
Antioxidant machinery within the cell can act to buffer the deleterious effects of high
ROS generation and redox stress. Reducing couples, such as glutathione (GSH) and glutathione
disulfide (GSSG), can be measured and used to calculate the redox potential (Eh), or capacity of
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the couple to buffer ROS. Measuring the concentrations of oxidized and reduced forms of
glutathione allows for a snapshot of the reducing power, or redox potential (Eh), of this
antioxidant couple via the Nernst equation (Harris et al., 2013; Timme-Laragy et al., 2018). The
GSH Eh is measured in negative mV; the more negative the Eh, the more reduced or capable GSH
is to buffer redox stress, while the more positive the Eh, the more oxidized and incapable of
buffering stress. As the redox state becomes more oxidized (less GSH), differentiation may
occur. For example, in a more reduced state (high GSH concentration), cellular processes such
as proliferation are favored. However, too much of an oxidizing shift in the GSH Eh can lead to
apoptosis and necrosis, because GSH is no longer capable of buffering the redox stress. When
measured over time, the GSH Eh reveals how constant or dynamic the redox state of the cells or
tissue is during normal development, or in response to toxicant exposure. This tool has been
employed in several developmental models, including zebrafish (Timme-Laragy et al., 2013),
mouse (Gardiner and Reed, 1995), and rat (Jilek et al., 2015), to characterize normal and
abnormal development.
Chicken Embryo Model
The chicken embryo has been used to study vertebrate embryo development since the
1600s (Stern, 2005). The chick is a relatively inexpensive model that allows for easy access to
the embryo, without complicating maternal factors. During the early stages of development, the
chicken embryo develops similarly to the human embryo. Manipulation of the chick embryo is
easy via in or ex ovo techniques such as windowing or EC culture (Chapman et al., 2001). The
chicken genome has been sequenced, allowing for the examination and discovery of key
developmental genes.
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The Hamburger-Hamilton (HH) stages are associated individual stages with hours/days
of development post fertilization (3.5 h-21 days) and somite number (Hamburger and Hamilton,
1951). To examine the effects of toxicants on neural tube closure, eggs must be incubated to
allow chick embryos to develop to HH Stage 8 (28-32 h), a stage described by 3-5 somite pairs
having formed. At this point during development, the neural folds have risen and begin to fuse at
the dorsal midbrain (Bellairs and Osmond, 2005). The anterior neural tube closes completely by
HH stage 12 (16 somites), while the posterior neural tube closes between stages 13- 14 (20-23
somites; (Schoenwolf, 1979). This closure is completed, in normal embryos, during the 24 h
treatment window used in our experiments.
While working heavily with embryo collections and drug exposures, I was able to publish
a methods book chapter in Developmental Toxicology (Stark and Ross, 2019), refining and
introducing new procedures for utilizing the chick embryo as a model for toxicological studies.
Methods described in later chapters include modifications and techniques that I have adapted for
this work.
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Study Design
The purpose of this research was to study the effects of three toxicants (ceramide,
fumonisin and VPA) on embryo development using the chick embryo and cell culture models.
Four distinct aims were proposes: 1) Assess the effects…of chicken embryos treated with
ceramide, fumonisin or VPA, 2) evaluate changes in the oxidative state of embryonic tissue, 3)
perform histological analysis of the neural tube, and 4) report differential gene expression
profiles of chicken embryos treated with ceramide, fumonisin, or valproic acid.
Experimental Set Up
To determine the effects of C2-ceramide (C2), fumonisin B1 (FB1), and valproic acid
(VPA) on undifferentiated and differentiated cells. This pluripotent Cells were cultured with
various concentrations of C2, FB1, or VPA for up to 24 hours after which samples were
collected to assess viability (MTT assay), changes in cellular redox state (glutathione redox
potential analysis), and neuronal differentiation.
For embryo studies, chicken embryos (HH8) were incubated on 6-well agar plates with
C2, FB1, or VPA for up to 24 hours. Embryos were collected and assessed for morphological
and histological changes, staining included Pax3 (NTC transcription factor), PH3 (cellular
proliferation marker), and LysoTracker (cell death marker). Glutathione (GSH) redox potential
(Eh) was analyzed to assess changes in tissue redox state over a 24-hour period under each
treatment. Embryos treated for 12 hours were collected for RNA sequencing analysis.
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Specific Aims


Characterize the effects of ceramide (C2), fumonisin (FB1), and valproic acid (VPA) on
cellular viability, differentiation, and oxidative state.



Evaluate morphological and histological changes in the developing neural tube of
embryos treated with C2, FB1, or VPA.



Determine whether changes in the redox state of embryonic tissue is altered under
treatment conditions, and whether those changes are similar or different across
treatments.



Evaluate and compare gene expression profiles of embryos treated with C2, FB1, or VPA
during neural tube closure.
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Figure 1.3: Experimental Models and Treatment Timeline.
(A) P19 cells are cultured with C2, FB1, or VPA as undifferentiated cells, or initially treated
with retinoic acid (RA) to induce neuronal differentiation prior to drug treatment. Cells were
assessed for viability, reactive oxygen species (ROS) generation, glutathione redox potential
(GSH Eh) analysis, and differentiation potential. (B) Chick embryos were collected from the
egg at HH Stage 8 (3-5) somites and incubated with C2, FB1, or VPA for up to 24 hours. (C)
Cell and embryo experimentation timeline.
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CHAPTER 2: Embryonic Exposure to C2-ceramide Alters Embryonic Development
and Increases the Frequency of Neural Tube Defects
Introduction
One of the major eukaryotic lipid groups, sphingolipids are associated with nearly every
cellular pathway one might study. Ceramides are structural and functional membranous
components located in the body at the center of sphingolipid metabolism (Castro et al., 2014;
Bocheńska and Gabig-Cimińska, 2020). With a sphingolipid backbone linked to an acyl chain of
2-24+ carbons, various ceramide species influence cellular location and function throughout the
body (Figure 2.1 A). Several metabolic and neurological diseases have been associated with
altered expression of ceramides, including type two diabetes, obesity, Parkinson’s, Alzheimer’s,
Gaucher’s, Crabbe’s, and Neimann-Pick’s disease (Haus et al., 2009; Brozinick et al., 2013;
Mencarelli and Martinez-Martinez, 2013). In obese individuals, where global ceramide levels
are elevated, bariatric surgery has shown to decrease overall weight and lower circulating plasma
ceramide levels (Huang et al., 2011).
Ceramides are generated via three different pathways: de novo synthesis, the salvage
pathway, and sphingomyelin hydrolysis (See Figure 2.1 B). De novo synthesis occurs within the
outer leaflet of endoplasmic reticulum (ER) membrane (Michel et al., 1997) or within the
mitochondria (Bionda et al., 2004), where serine and palmitoyl-CoA are condensed and reduced
to produce sphinganine. Sphinganine is acetylated by ceramide synthase (CerS) to
dihydroceramide, which is then converted to ceramide by ceramide dehydrogenase (Grosch et
al., 2012).
Six human CerS enzymes have been identified, each displaying preference in generating
certain ceramide species (Mullen et al., 2012; Park et al., 2014). CerS is activated in response to
a host of stimuli, including heat stress, UV radiation, chemotherapy, apoptotic signals, stress
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response, apoptosis, and cell cycling (Rotolo et al., 2005; Siskind et al., 2010; Hoeferlin et al.,
2013). Ceramide generation via different CerS are known to is known to function distinctly
within mammalian systems (Laviad et al., 2008; Park et al., 2014). For example, in insulin
resistant metabolic disorders, C16-ceramides (CerS6) in the liver and C18-ceramides (CerS1) in
skeletal muscle (Blachnio-Zabielska et al., 2016) contribute to insulin resistance, while CerS2
generated ceramides promote insulin sensitivity (Mahfouz et al., 2014; Raichur et al., 2014).
Ceramides influence cell death, differentiation, proliferation, migration, and cycle arrest.
Other cellular and tissue fates, including autophagy, necrosis, mitophagy, cytoskeletal
rearrangement, metabolism, and insulin signaling, are associated with ceramide mis-regulation.
Additionally, ceramide is created via hydrolysis and salvage pathways. Hydrolysis of
sphingomyelin occurs in a similar fashion, generating ceramide and phosphorylchlorine
(Hannun, 1994). The enzymatic activity of SMase depends upon the pH, thus allowing for
subcellular localization of sphingomyelin hydrolysis (Mencarelli and Martinez-Martinez, 2013).
SMase concentration and location allow for variable ceramide populations and ratios within cells
and the body. The salvage pathway utilizes the reverse functionality of the ceramidase (CDase)
enzyme. Similar to SMase, CDase condensation of sphingosine and fatty acyl-CoA molecules
generates new ceramides within the lysosomes (Bar et al., 2001), mitochondria (El Bawab et al.,
2000), and nuclear membranes (Shiraishi et al., 2003).
Under normal physiological conditions, the most common ceramide species are C16:0
(palmitic) and C18:0 (stearic) fatty acids (Mencarelli and Martinez-Martinez, 2013). Long chain
C18:0 is the most common ceramide within neural tissue. Under diabetic and obese conditions,
serum C18:0, C20:0, and C24:1 basal concentrations are elevated, while C18:0 ceramides and
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Figure 2.1: Ceramide Structure and Synthesis.
(A) Ceramides are members of the sphingolipid fatty acid family. Ceramide molecules
contain an 18-carbon sphingoid backbone and an N-acetylated chain of 2-26 carbons (most
common are ceramide species with N-acyl chains of 16-26 carbons). Example is a C16:0
molecule. (B) Ceramides are generated via three different pathways: de novo (endoplasmic
reticulum), hydrolysis (plasma membrane), and salvage (lysosomes). Each pathway regulates
ceramide localization, generating ceramides that perform different functions. Modification
and packaging of ceramides into more complex glycosphingolipids occurs within the Golgi
apparatus prior to cellular use and distribution.
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total dihydroceramide concentrations are higher in T2D, correlating positively with insulin
resistance (Haus et al., 2009; Lopez et al., 2013; Bergman et al., 2015).
Ceramides play an integral role in cellular processes such as stress response, cell cycling,
cell death, and proliferation, serving as key regulators (Scarlatti et al., 2004). These bioactive
lipids respond to stimuli and act as second messengers in systems associated with cellular
differentiation, growth, and apoptosis, and thus purport a potential role during development
(Jembrek et al., 2015). More specific to neurogenesis, lipid rafts of neuronal cells contain
significantly higher levels of ceramides compared to levels observed in other somatic cells
(Mencarelli and Martinez-Martinez, 2013). These rafts are important in neuronal cell adhesion
(Povlsen and Ditlevsen, 2010) synaptic protein localization and nerve conduction (Hering et al.,
2003), neurotransmitter receptor stabilization (Bruses et al., 2001), and axon guidance
(Kamiguchi, 2006). Additionally, lipid rafts are involved in cell-cell interactions, protein
binding, protein trafficking and signal transduction (Simons and Ikonen, 1997; Jin et al., 2011).
Several neurodegenerative diseases have been associated with ceramide imbalance, including
Alzheimer’s, Parkinson’s, Niemann-Pick’s, Gaucher’s, and Krabbe’s disease (Mencarelli and
Martinez-Martinez, 2013). Autophagy is also regulated by ceramides through disrupting protein
function and altering gene expression (Scarlatti et al., 2004). In studying the effects of longchain highly hydrophobic fatty acids like C18:0, a short chain analog (C2 or C6) is often
employed experimentally due to increased solubility and hydrophilic properties. While C2 and
C6 exist within mammalian cells they are not the predominant species. Normally located in the
brain and liver, the hydrophilic C2 is commonly used experimentally to mimic the longer
ceramides in biological systems and is thought to be quickly modified to longer chain ceramides
(Abe et al., 1996; Zheng et al., 1999; Mencarelli and Martinez-Martinez, 2013).
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Ceramides have never been explored as a cause for NTDs, with only a few reports
implicating components of the sphingolipid metabolism pathway (Sadler et al., 2002; Gelineauvan Waes et al., 2012). Environmental influences such as oxidative stress, have been welldocumented in cases of NTDs, such as those associated with exposure with valproic acid (Tung
and Winn, 2011), benzo-pyrenes (Lin et al., 2018), arsenic (Han et al., 2011), and in cases of
folate deficiency (Lee et al., 2011). Interestingly, ceramides have been associated with oxidative
stress (Quillet-Mary et al., 1997; Petrache et al., 2005; Kasumov et al., 2015). Linking elevated
ceramides and an increased risk for NTDs in obesity and diabetes, we hypothesized that altered
ceramide profiles under conditions of maternal obesity induce oxidative stress in embryonic
tissue, resulting in an increased risk for neural tube or other defects. This study used a
combination of P19 cells and chick embryos to test for in vitro and in vivo effects and potential
mechanisms of ceramide exposure on neural tube closure.
Methods

Cell Culture
P19 mouse embryonal carcinoma cells were obtained from American Type Culture
Collections (ATCC) and cultured in alpha-modified minimum essential medium (Thermo Fisher)
supplemented with 7.5% (v/v) bovine calf serum (ATCC), 2.5% (v/v) fetal bovine serum
(Genesee), 100 units/mL penicillin (Genesee), and 100 μg/mL streptomycin (Genesee), in a
humidified incubator gassed at 5% CO2 and heated to 37 °C.
Neuronal differentiation was carried out as described per Laplante et al. (2004). In brief,
cells were seeded at a density of 1 x 106 cells per 60 mm bacteria grade petri dish, treated with 1
μM retinoic acid (Sigma-Aldrich), and cultured as aggregates from day 0 to day 4 (D0-D4). On
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D4, aggregates were removed and centrifuged at 1000 rpm for 5 min at room temperature. The
pellets were dissociated in 0.05 % trypsin (Genesee) supplemented with 10 μL/mL of 1,000 U
DNase 1 (Thermo Fisher) and incubated in a water bath at 37 °C for 5 min with gentle rocking.
Single cells were seeded at a density of 40,000 cells/cm2 on gelatin-coated tissue culture dishes
in Neurobasal medium (Thermo Fisher) supplemented with 0.5 mM L-glutamine (Genesee), 2%
(v/v) B27 supplement (Thermo Fisher), 100 units/mL penicillin, and 100 μg/mL streptomycin
until treatment on D7.

Embryo Culture
The EC culture method has been employed in our lab to observe chick embryo
development under tightly controlled conditions, including in the presence of developmental
pathway inhibitors (Voelkel et al., 2014). Because the chemical inhibitors are added to the agar
bed that underlies the embryo in EC culture, higher concentrations are used than in cell culture
experiments.
Fertilized chicken eggs were obtained from local vendors and stored at 12-17°C for up to
two weeks. Eggs were incubated at 38.5°C for 28-32 h to Hamburger & Hamilton (HH) stage 8
(3-5 somite stage). Embryos were collected using early chick (EC) culture method described
Chapman et al. (2001). Briefly, for each embryo, an egg was cracked into a 100-mm petri dish
with the embryo floating atop the yolk. Thick albumin was retracted from the top of the yolk
near the embryo and a filter paper disc (1” disc with a ½” hole in the center) was placed on the
yolk with the embryo in the center. Each embryo was collected by cutting the vitelline membrane
completely around the disc and carefully lifting the disc with the adhered vitelline membrane and
suspended embryo from the yolk. A second filter paper disc was placed on the ventral side to
create a sandwich. Embryo discs were placed in a 100-mm petri dish with fresh 1x PBS, and
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subsequently plated on DMSO control (0.5% DMSO) or C2-ceramide (C2; 50-100 µM) treated
six-well agar plates (described under Ceramide Dose Curve). Embryos were incubated on the
plates for a specified time before being removed into fresh 1x PBS for imaging.

MTT Assay
P19 cells were seeded at a density of 1 x 105 cells/well in a 96-well plate and treated with
varying concentrations of C2 (6.25-800 µM) for 24 h. Following exposure, cell viability was
measured using a 3-[4,5- dimethylthiazol-2- yl]-2,5 diphenyltetrazolium bromide (MTT) assay,
which is based on the ability of cells to cleave MTT to an insoluble violet formazan product by
the activity of mitochondrial dehydrogenases. At the end of the treatment period, 0.5 mg/mL
MTT (Sigma-Aldrich) was added to the medium and incubated for 3 h at 37°C. The formazan
dye was dissolved by adding 100 μL DMSO to each well, and the absorbance was measured with
an automatic microplate reader at 590 nm.

Dose Curve Analysis
Long chain ceramides (C16-C24), while more physiologically relevant are hydrophobic
and difficult to study. Therefore, the hydrophilic short chain ceramide C2 is used as an
experimental analog to study the effects of ceramide-mediated processes. C2 concentrations of 0
µM, 50 µM and 100 µM were tested to determine frequency of NTDs and development in
chicken embryos. Chicken embryos were incubated to HH8 and collected onto C2 treated plates
of 0 µM, 50 µM and 100 µM. Embryos were incubated for 24 h, after which somite count and
morphological analysis were compared between groups. Whole and sectioned embryos were
evaluated to determine open and closed NTDs. Six-well plate preparation for chicken embryo
culture was as follows:
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Ceramide Plate
A C2 (Cayman Chemical) stock solution of 20.91 mM (1 mg/140 μL DMSO) was diluted
in 2 mL 1%BSA/PBS with PenStrep (1:1000) to 25, 50, or 100 µM. 6 mL thin albumin was
added, followed by 6 mL agar (0.18 g BactoAgar in 6 mL saline) to produce 14 mL
homogenized drug solution. 2 mL of the solution was added to each well of a 6 well plate and
refrigerated to solidify.

Control Plate
70 µL Dimethyl Sulfoxide (DMSO; Millipore) was added to 2 mL 1%BSA/PBS with
PenStrep (1:1000). 6 mL thin albumin was added, followed by 6 mL Agar (0.18 g BactoAgar in
saline) to produce 14 mL homogenized drug solution. 2 mL of the solution was added to each
well of a 6 well plate and refrigerated to solidify.

Morphological Analysis
Embryos were incubated sequentially at 37 ºC for 2 hours in 5% and 15% sucrose in 1x
PBS before embedded in gelatin for cryosectioning. Twelve µm sections were mounted on
Superfrost Plus glass slides and gelatin was removed in PBS for ten minutes at 37 ºC. Embryo
sections were incubated with 1:500 dilution of laminin primary antibody (3h11; Developmental
Studies Hybridoma Bank) or 1:250 Pax3 (Developmental Hybridoma Bank) in 0.1% BSA/PBS
(bovine serum albumen, with 0.1% Tween-20) at 4 ºC overnight. The primary antibody was
rinsed twice in PBS for ten minutes at room temperature before being covered with 1:1000
dilution of Alexa-488-conjugated goat anti-mouse IgG2a (Invitrogen), Alexa-546-conjugated
anti-rabbit IgG (Invitrogen), or Alexa-633-conjugated goat anti-mouse IgG1 (Invitrogen) in
BSA/PBS buffer. Tissue sections were incubated for one hour at room temperature. Slides were
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then rinsed in PBS for ten minutes. DAPI (Sigma) was used to visualize nuclei with 1:10,000
dilution. Antibody staining was visualized and imaged using an Olympus BX-61 fluorescent
microscope and CellSense software.

Statistics
Data was analyzed using Microsoft Excel 2016 and Prism 7 software. A confidence
interval of 95% (α=0.05) was used as threshold for statistical significance. Data are presented as
mean ± SEM, with sample size (n) specified in the corresponding figure.
P19 Cells. Statistical significance was measured with Two-Way ANOVA and Dunnett’s
multiple comparison tests (MTT) or Tukey’s multiple comparison tests (GSH and DCF).
Chick Embryos. Statistical analysis was conducted with Two-Way ANOVA and
Bonferroni (GSH, PH3, and LT) multiple comparison tests, Paired T-Test (DCF), Unpaired Ttest (somite number) or Kruskal-Wallace and Welch’s t-tests (dose curve, NTD type).
Results
To understand the mechanism leading to embryo defects, it was important to evaluate the
overall cellular effects of C2-ceramide (C2) in a tightly controlled in vitro system. We first
explored the effects of C2 on an immortalized cell line (P19 cells) that could be differentiated
into neuronal precursors, as the neural tube is the structure to give rise to the brain and spinal
cord. We discovered that shifts in redox potential occurred, and there was some evidence of
oxidative stress in the absence of apoptosis or necrosis. When comparing cell culture data with
observations in embryo tissue, some similarities, but also important differences, were observed.
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Cell Viability is Unchanged, but ROS Accumulates in C2-Treated P19 Cells
To more comprehensively assess the effects of C2 on early neurulation, assays were done
in cell culture, thereby informing future experiments in embryos. P19 cells were selected due to
their similarity to neuronal precursor cells (Kim et al., 2001), such as might be found in the early
neural tube. Moreover, P19 cells have been used previously as a model of neurogenesis and
neurotoxicity (Pashkovskaia et al., 2018) and diabetic embryopathy (Chang et al., 2003), and
thus provide a reliable, effective means to evaluate the effects of C2 in vitro.
With any toxicant, cellular damage leading to necrosis or apoptosis is an important
consideration. Undifferentiated P19 cell viability was assessed using several concentrations of
C2, ranging from 6.25-200 µM (n=4 at each dose tested). Cell viability, as assessed by culturing
undifferentiated P19 cells with 100 μM DCF-DA and then treating with different concentrations
of C2 (6.25-800 µM) and measuring changes in fluorescent intensity, was not affected except at
200 µM (Figure 2.2 A), where it decreased significantly (p<0.0001). From this, we concluded
that C2 exposure below 200 µM was not cytotoxic to undifferentiated P19 cells, thereby
informing planned experiments in embryos.
Because ceramide is known to induce oxidative stress, ROS generation was measured in
P19 cells exposed to non-cytotoxic concentrations of C2 (25-100 µM) using the DCF assay.
ROS generation increased in undifferentiated P19 cells in a dose-dependent manner (Figure 2.2
B), as shown by a significant increase in the percent change of fluorescence being seen at 75 µM
(p=0.0413) and 100 µM (p=0.015), showing that ROS is generated in absence of cell death. We
therefore hypothesized that ROS generation would be seen in undifferentiated neuroepithelial
cells in embryos.
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Figure 2.2: P19 Cell Viability and Reactive Oxygen Species Generation.
Undifferentiated P19 neural precursor cell viability was assessed using an MTT Assay to
determine the toxicity of C2 on living cells (A). P19 cells were exposed to 6.25-200 µM
concentrations for 24 h (n=4). Cell viability dropped significantly only at 200 µM C2
(p<0.0001). Reactive oxygen species (ROS) generation increased significantly in C2 treated
undifferentiated P19 cells at 75 µM (p=0.0413) and 100 µM (p=0.015), as indicated by the
change in percent of DCF fluorescence compared to control (n=4). Asterisks denote
significance between 100 µM and other treatments (*= p≤0.05, **= p≤0.01, ***= p≤0.001,
****= p≤0.00001).
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Glutathione Analysis of Differentiated and Undifferentiated P19 Cells Reveals Unique Cellular
Redox Shifts After C2 Treatment
With results showing good cellular viability, but ROS accumulation after C2 exposure
between 75-100 µM concentrations, we assessed shifts in the cellular redox state of P19 cells as
measured by glutathione redox couple HPLC analysis. Undifferentiated P19 cells were exposed
to C2 (10-100 µM) over 48 h to determine the effect on cellular GSH Eh (Figure 2.3 A). For
most treatment concentrations, no differences were observed at any time point between
experimental and control samples, including at 100 µM C2.
Interestingly, no differences occurred in total concentrations of GSH and GSSG in the
undifferentiated C2-treated P19 samples compared to controls (Figure 2.3 B-C), indicating C2
treatment does not alter GSH concentrations or redox potential.
It is known that cells and tissues can exhibit dramatically different redox profiles
depending on their differentiation state (Hansen and Harris, 2015). To evaluate whether C2
exposure affected the GSH Eh in a model of differentiated, neuronal cells, P19 cells were
differentiated into neurons, and then treated with varying concentrations of C2 (10-100 µM),
with measurements taken at 4, 8, 12, 24, 36, and 48 h (Figure 2.3 D). When comparing
treatments to controls, GSH Eh was more oxidized only in differentiated cells treated with 100
µM C2, beginning at 24 h and continued through 48 h (p<0.0001).
At 24 h, GSH concentrations were significantly decreased in differentiated cells treated
with100 µM C2 compared to controls (p=0.0003; Figure 2.3 E). Lower GSH concentrations
were observed in 50 µM C2-treated samples when compared to control at 24 h (p=0.0455) and
36 h (p=0.0008). No differences were seen at any time point with 10 µM C2. Differentiated P19
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Figure 2.3: Glutathione Analysis of C2-Ceramide Treated Differentiated and
Undifferentiated P19 Cells over 48 hour Period.
(A-C) Undifferentiated P19 cells were treated with 10, 50, or 100 µM C2 for 4, 8, 12, 24, 36
or 48 h and collected for GSH redox potential (Eh) analysis. No significant difference was
observed between treatments and control. (A). Glutathione and GSSG concentrations did not
vary between treatments (B, C). D-F. Differentiated P19 cells were similarly incubated and
collected for GSH Eh analysis. 100 µM C2 treatment induced a significant oxidizing shift at
24, 36 and 48 h in the GSH Eh when compared to controls (p<0.0001; D). A comparison of
GSH concentrations show significantly lower concentrations in 100 µM C2 when compared
to control 24 h (p<0.0001), 36 h (p=0.0003), and 48 h (p=0.0004; E). 50 µM C2-treated
samples showed lower GSH levels when compared to control at 24 h (p=0.0455) and 36 h
(p=0.0008). GSSG concentrations differed between control and 100 µM C2 at 36 h (p=0.009)
and 48 h (p=0.0368; F). Asterisks denote significance between 100 µM and control (*=
p≤0.05, **= p≤0.01, ***= p≤0.001, ****= p≤0.00001). # = significance between 50 µM C2
and control.
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GSSG concentrations were lower with 100 µM C2 treatment compared to control at 36 h
(p=0.009), and at 48 h (p=0.0368; Figure 2.3 F).
Cellular redox states have been shown to become increasingly oxidized as cells become
increasingly differentiated. Here, P19 cell redox states recapture that feature and also shift to a
more oxidizing redox state as neurogenesis occurs. As such, susceptibility to C2 treatments
between undifferentiated and differentiated P19 cells may be a consequence of inherent redox
shifts in the GSH Eh during differentiation to a more oxidizing state, providing rationale as to
why more reducing, undifferentiated cells are more resistant to C2-induced oxidation. While the
preliminary P19 cell work informed future direction, experimentation in whole embryos depicts
more accurately the effects of C2 in a system that contains numerous cells types, including
neuronal precursors, in a three-dimensional structure.

Cellular Proliferation is Decreased, While Cell Death and Embryo Viability are Unchanged
Under C2 Treatment
Using the P19 cell culture data above to inform embryo experimental design, we first
looked at cell proliferation and death, and ROS accumulation. Phospho-histone 3 (PH3) is a
marker for cellular mitosis and is thus used to visualize proliferating cells. Chick embryos
(HH8) were incubated on C2- or DMSO-treated agar plates for 24 hours. Embryos were then
sectioned and stained with PH3 antibody. Sections were grouped into four regions of interest:
Head, Otic, Upper Spinal Cord (USC), and Lower Spinal Cord (LSC). Total count and count
within the neural tube of PH3+ cells were measured for each section. As shown in Table 2.1 and
Figure 2.4, most regions showed a statistically significant reduction in PH3+ cell after C2
treatment, even though high variability was observed across sections in both C2-treated and
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Table 2.1: Comparison of the Cellular Proliferation Globally and Within the Neural Tubes of
C2-Treated and Control Embryos.
Tissue sections were analyzed for C2- and DMSO-treated embryos to obtain PH3+ (marker for
M phase) cell counts. Sections were grouped by region based on location along the A-P axis in
four groups: Head, Otic, Upper Spinal Cord (USC), and Lower Spinal Cord (LSC). Due to high
variability, an average PH3+ cell count is reported for all sections and an average within the
neural tube (NT). A sample size of 4-5 embryos was analyzed per group. Head: PH3+ cell
counts were significantly different for both total and NT averages (p<0.0001). Otic: No
significance was observed between treated (n=5) and control (n=5) total PH3+ count (p=0.4622),
however, significance was observed between average PH3+ cell counts within the neural tube
(p=0.0181). USC: PH3+ cell counts varied significantly between DMSO (n=5) and C2-treated
(n=5) embryos both in total average count, 46.06 (p=0.0006), and in NT average count, 13.04
(p<0.0001). LSC: Significance was observed between average cell counts in the lower region of
C2 (n=5) and DMSO (n=4) treated embryos in total PH3+ cell count (p=0.034), however no
significant difference was seen in the average number of proliferating cells within the NT
(p=0.8957).
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Figure 2.4: PH3 Cellular Proliferation Analysis of C2-Ceramide Treatment.
C2- and DMSO-treated embryonic tissue sections were analyzed and PH3+ (marker for M
phase) cell counts were collected to measure cellular proliferation, both globally and within
the neural tube. Sections were grouped by region based on location along the A-P axis in four
groups: Head, Otic, Upper Spinal Cord (USC), and Lower Spinal Cord (LSC). Global cellular
proliferation was significantly reduced in embryonic sections within the Head (<0.0001),
USC (p=0.0006), and LSC (p=0.034) regions. Within the neural tube, fewer proliferating
cells were counted in the Head (p<0.0001), Otic (p=0.018), and USC (p<0.0001) regions.
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control embryos. The Otic region was not significantly different when counting cells in the entire
section (p=0.4622), and the LSC region was not significantly different when counting PH3+ cells
in the neural tube (p=0.8957). Overall, we conclude that C2 treatment resulted in a global
reduction in cell proliferation.
To assess early apoptosis, embryos were cultured in the presence of DMSO (control;
n=5) or 100 µM C2 (n=6) for 24 h. LysoTracker Red (LT) punctae, a readout of acidic
lysosomes and a marker of apoptosis, were quantified in histological sections (Figure 2.5 AB). Results revealed that when comparing control and C2-treated embryos, no significant
difference was found in the total number of LT-positive acidic lysosomes (p=0.8106), or in the
number of LT-positive acidic lysosomes found just within the neural tube (Figure 2.5 C).
Cranial vs. caudal sections and open vs. closed neural tubes also showed no difference (data not
shown).

ROS Generation is Unaffected, but Glutathione Redox States are Altered in C2-Treated Embryos
To determine whether there was a difference in ROS generation in embryos, we
employed a whole-mount DCF assay. Measurements were specifically taken from the
developing cranial neural folds and the area adjacent to the somites (Figure 2.6 A-B). A
comparison of the relative DCF fluorescence in the neural folds of embryos incubated in 100 µM
C2 indicates that overall ROS generation increases an average of 45.06% in C2-treated embryos
compared to 41.6% in controls in a 16-minute time course (Figure 2.6 C). While the neural folds
of the C2-treated embryos (Figure 2.6 B) appeared brighter than those of the control embryos
(Figure 2.6 A), no statistical significance was observed.
Early stage chick embryos (3-5 somite stage) were exposed to 100 µM C2-ceramide for
several time points from one to 24 h and evaluated for changes to GSH Eh. Exposure to C2
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Figure 2.5: Embryonic Apoptosis is Unaffected by C2-Ceramide Treatment.
(A-D) LysoTracker Red Lysosomal Stain. Analysis of control (n=5) and C2 treated embryos
(n=6) revealed there is no difference in cell death activity throughout the embryo or within
the neural tube (A-B). Quantification revealed no statistical difference in the total number of
acidic lysosomal punctae or number of punctae within the neural tube (C). No difference was
observed between cranial or caudal sections (data not shown).
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Figure 2.6: ROS Generation Unchanged After Embryonic C2-Ceramide Treatment.
Analysis of reactive oxygen species (ROS) generation was measured in HH8 chick embryos
treated with DMSO (A) or C2 (B) using a DCF assay. Percent change in relative fluorescence
over a 16 min period showed no statistical difference in ROS generation between control and
C2 embryos (p=0.2104; C).
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quickly led to an oxidizing shift in embryonic GSH redox state at 1 h (p<0.0001), 2 h
(p=0.0096), 4 h (p<0.0001), and 8 h (p=0.0006) when compared to control embryos (Figure 2.7
A).
Embryonic GSH concentrations were significantly lower compared to controls at 1, 2, 4,
and 8 h (p<0.0001) after incubation (Figure 2.7 B). Interestingly, GSSG concentrations did not
vary at any time point (Figure 2.7 C). Total GSH levels ([reduced GSH] +2[oxidized GSSG])
were significantly reduced between 1-8 h after incubation (p<0.0001; Figure 2.7 D). Albeit the
timing of GSH redox changes is different in cells vs. embryos, similarities in C2-induced redox
changes between models occur, where decreased GSH drives changes to the cellular GSH Eh, not
an increase in GSSG.

Pax3 Expression is Unchanged in C2-Treated Embryos
Pax3 is a transcription factor known to regulate several key developmental genes,
including many involved in neural tube closure (Mayanil et al., 2001; Sanders et al., 2014).
Under hyperglycemic conditions, such as those found in maternal diabetes, oxidative stress has
been shown to disrupt Pax3 expression (Li et al., 2005; Loeken, 2005). While C2 treatment did
not result in ROS generation as measured by DCF, a clear shift in the GSH Eh was observed.
Therefore, we examined whether C2 treatment altered Pax3 expression in exposed embryos
(n=5) compared to control embryos (n=5). No difference was observed in Pax3 expression
between DMSO control and C2-treated embryos within the ectoderm, neural crest cells, dorsal
neural tube, or somites (see Figure 2.8). Additionally, no Pax3 expression was observed in
control or treated embryos in regions where NTDs were observed in the caudal end where
segmental plate mesoderm has not yet formed somites (see Figure 2.8 “Caudal” and Figure 2.10
C).
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Figure 2.7: Glutathione Analysis of C2-Ceramide Treated Chick Embryos over 24 h Period.
HH8 chick embryos were incubated on agar plates containing 100 µM C2 for 1, 2, 4, 8, 12, or
24 h, and collected for GSH analysis. A. Glutathione (GSH) redox potential (Eh) analysis
revealed exposure to C2 resulted in an oxidizing shift in the Eh of the tissue that was
significantly different when compared to control at 1 h (p<0.0001), 2 h (p=0.0096), 4 h
(p<0.0001), and 8 h (p=0.0006). By 12 h, the state of the tissue recovered to normal
conditions. B. Reduced GSH concentrations were significantly lower at 1, 2, 4, and 8 h after
incubation (p<0.0001) when compared to control. C. GSSG concentrations were not different
from control at any point over the 24 h time course. D. Total GSH concentrations (total
GSH=[reduced GSH] + 2[oxidized GSH]) were significantly reduced in C2 treated embryos
at 1 h, 2 h, 4 h, and 8 h when compared to control (p<0.0001). Asterisks denote significance
between 100 µM and other treatments (*= p≤0.05, **= p≤0.01, ***= p≤0.001, ****=
p≤0.00001).
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Figure 2.8: Pax3 Expression Profiles in Response to C2-Ceramide Treatment.
Pax3 expression was evaluated in regions along the A-P axis of C2-ceramide and DMSO
treated embryos (n=5). Embryonic sections were grouped according to their location within
the embryo into five groups: Head, Otic, Upper Spinal Cord (USC), Lower Spinal Cord
(LSC), and Caudal. Pax3 expression was present in the ectoderm and migrating neural crest
(Head), dorsal neural tube (USC, LSC), and somatic tissue (USC, LSC) regardless of neural
tube closure. Note: Cranial NTDs were present in 2/5 of the C2-treated embryos (Otic and
Caudal sections show defects).
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C2-Ceramide Causes an Increased Incidence of NTDs in Chick Embryos
Using the EC culture method, embryonic morphology was characterized in whole-mount,
with histological sections used to confirm gross observations of neural tube closure. Embryos
were cultured for 24 h with DMSO, and 50 or 100 µM C2, with C2-treatment increasing the
frequency of failed neural tube closure along the length of the A-P axis (Figure 2.9 C-D). Neural
tube defects occurred at the following rates: 12% in control embryos; 14% in 50 µM embryos;
and 45% in 100 µM embryos (Figure 2.9 E). While 50 µM C2 NTD rates were not statistically
different from controls, NTD prevalence of embryos treated with 100 µM was statistically higher
than that of control (p=0.0159). The seemingly high rate of NTDs in controls (12%) may be due
to the methodology used, where embryos are not cultured in ovo. However, the advantages of EC
culture allows for precise delivery and dosage of potential toxicants over time. The significant
increase in NTD occurrence after C2 exposure (45%), along with the other embryo data
presented shows NTDs occurring at a very high rate in the absence of detectable cytotoxicity in
embryos.
Somite formation was measured after 24 h in 100 µM C2-treated embryos (n=31) to
determine differences in overall growth and rate of development over time and compared to
control embryos (n=23). Initial somite number was recorded for each embryo prior to treatment,
with final somite number recorded upon embryo collection, and the difference was calculated
(Figure 2.9 F). No differences were observed in starting somite number mean (Control: 4.8±
0.13 vs. C2: 4.5±0.13), ending somite number mean (Control: 20.5±0.40 vs. C2: 19.3±0.67) or
difference in somites added over time (Control: 15.7±0.42 vs. C2:14.9±2.9). While the SD was
larger for C2-treated embryos, there was no correlation between starting somite number and
somites added over time. Therefore, no statistical difference was observed in embryo growth.
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Figure 2.9: Ceramide Dose Curve in Chick Embryos.
A-D. Observed Defects. Affected embryos exposed to 100 µM C2 developed cranial and caudal
defects like what is observed in human embryos with neural tube defects. Normal embryonic
growth was observed in control embryos (A). Cranial defects included minor as well as more
severe defects, including failed neural fold bending (B). Caudal defects like that shown in C
were commonly observed in affected embryos (somite formation was unaffected at the level of
the open folds). Open neural folds and failed vesicle formation, with a cruciform defect above
the otic cups, was also observed in some ceramide embryos (D). E. Ceramide Dose Curve.
Chick embryos were incubated on control (0.5% DMSO) or C2 containing (50 µM or 100 µM)
agar plates for 24 h. Control embryos experienced a neural tube defect (NTD) frequency of 13%
(n=24). Exposure to 50 µM ceramide resulted in a 14% NTD frequency (n=21), while 100 µM
C2 increased the frequency to 45% (n=44). 100 µM C2-induced NTD rate was statistically
significant when compared to control (p=0.0021) and 50 µM (p=0.0061). F. Total Increase in
Somite Pair Formation. No difference was observed in somite pair formation of treated embryos
when compared to control. C2 treated embryos developed an average of 14.8±2.9 somites over
24 h, while control embryos developed 15.7±0.4 somites (p=0.2749). Asterisks denote
significance between 100 µM and other treatments (*= p≤0.05, **= p≤0.01, ***= p≤0.001,
****= p≤0.00001).
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No differences were observed in embryo survival, as measured by viable heartbeat after 24 h
incubation, and gross anatomical differences such as overall length or distorted features were not
obvious, although absolute measurements in embryo length were not recorded.
To confirm open or closed status of the neural tube, histological analysis was performed
on treated and control embryos. Neural tube closure was evaluated, and defects were classified
as cranial only (defects from the anterior neuropore to the 10th somite; Figure 2.10 A-B), caudal
only (defects from the 11th somite to the posterior neuropore; Figure 2.10 C), or both
cranial+caudal (defects in both the cranial and caudal regions). DMSO control sections with
closed neural tubes are shown for comparison (Figure 2.10 A-C). A comparison of the number
of embryos with cranial, caudal, or cranial+caudal defects (Figure 2.10 D) revealed a
significantly greater number of embryos with cranial defects (n=10) compared to embryos with
both cranial+caudal defects (n=4; p=0.0052). There was no significance between the number of
embryos with cranial defects vs. caudal defects (n=6; p=0.0785) or embryos with caudal vs.
embryos with cranial+caudal defects (p=0.512).
Discussion
The data presented here show for the first time that embryonic exposure to C2-ceramide
(C2) resulted in an increased incidence of NTDs in early vertebrate embryos. As with many
environmental factors that influence development, the mechanism is elusive, but data presented
in this initial report supports redox dysregulation through the GSH Eh as a potential effector.
By initially using P19 mouse embryonic carcinoma cells as an in vitro model to evaluate
the effects of C2 exposure on neuronal precursor cells, we were able to establish several
important pieces of information. For example, proper C2 concentrations for embryo exposure
were determined where concentrations below 200 µM were non-cytotoxic, and the establishment
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Figure 2.10: C2-Ceramide Induced Neural Tube Defects.
(A-D) Cranial, caudal, and both cranial + caudal neural tube defects (NTDs) were visible in
C2 ceramide (C2)-treated embryos. Brightfield and fluorescent images of cross sections show
cranial NTDs in C2-treated embryos in the rostral hindbrain (A), the caudal hindbrain (B),
and the caudal region of the embryo (C), compared to closed neural tube sections of control
(DMSO-treated) embryos. Laminin and DAPI overlays for each section shows a continuous
basement membrane in DMSO-treated embryos and a clear opening in the neural tube of C2treated embryos. D. NTD Type Comparison. A comparison of the number of NTDs observed
in C2 treated embryos. The number of embryos with cranial defects was significantly
different from the number of embryos with cranial+caudal defects (p=0.0052). Asterisks
denote significance between 100 µM and other treatments (*= p≤0.05, **= p≤0.01, ***=
p≤0.001, ****= p≤0.00001).
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of C2-induced ROS generation at concentrations of ≥75 µM (Figure 2.2 A-B). From this
preliminary data, we used 50 and 100 µM C2 concentrations in subsequent embryo experiments.
The cell culture data also revealed interesting differences between differentiated and
undifferentiated P19 cells. This observation was important, since the tissue of a developing
embryo is rich with various cell types, including undifferentiated, differentiating, and
differentiated cells. Interestingly, past studies showed that some cell types, including human
neuroblastoma, PC12, and rat hippocampal cells, are sensitive at lower concentrations (FranceLanord et al., 1997; Darios et al., 2003; Prasad et al., 2008; Czubowicz and Strosznajder, 2014),
suggesting some cell types are more vulnerable to the oxidizing effects of C2 than others. Here,
differences were observed when comparing the effects of C2 on cellular redox state of
undifferentiated vs. differentiated P19 embryonic carcinoma cells. Glutathione redox potential
(GSH Eh) measurements revealed no difference between C2-treated and control treated samples
in undifferentiated cells (Figure 2.3 A), while in differentiated cells, GSH Eh was altered,
becoming significantly more oxidized (Figure 2.3 D). These findings are consistent with
previous research that shows similar trends of differentiated cells having more oxidizing GSH Eh
than their undifferentiated counterparts during adipogenesis and osteogenesis (Imhoff & Hansen,
2011). The initial redox state of differentiated P19 cells is more oxidized than that of
undifferentiated cells. Therefore, C2 exposure results in a greater oxidizing shift (toward a state
that would lead to apoptosis or necrosis) only in differentiated P19 cells. Clearly, the differences
require more in-depth study to better understand these outcomes, but these initial results suggest
cellular susceptibility based on the state of differentiation.
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Embryonic Defect Data
In chicken embryos, the neural folds begin to fuse in the midbrain by developmental
stage HH8 (3-5 somites; (Bellairs and Osmond, 2005). Closure of the anterior neuropore is
complete by stage 12 (16 somites), and the posterior neuropore closes between stages 13- 14 (2023 somites; (Schoenwolf, 1979). Therefore, to analyze the effects of C2 exposure on the redox
state of the tissue during the period of neural tube closure (26-53 h after fertilization), embryos
were cultured on six well agar plates with 100 µM C2 and compared to control embryos. Neural
tube defects were seen in 45% of C2 treated embryos, a frequency 3x that of control embryos
(Figure 2.9 A-D). To understand potential mechanisms, we examined cell proliferation and
death, ROS generation, pax3 expression, and redox potential.
Fewer PH3+ cells were observed in embryos after C2 treatment, indicating a reduction in
cell proliferation. This change in cell proliferation is minor enough, or has late enough onset, so
as to not create an obvious difference in embryo size, since this was not a consistent observation
through the many experiments performed over time. Two potential hypotheses for this reduced
proliferation are 1) an overall reduction in cellular metabolism due to C2 treatment impacting
mitochondrial function, and 2) ciliary disruption due to C2 treatment disrupts cellular
functionality and division. Ceramides are implicated in reducing the mitochondrial respiration of
skeletal muscle cells (Hodson et al., 2015; Taylor et al., 2017), and several lines of study have
indicated a potential role of primary cilium in the development of NTDs (Murdoch and Copp,
2010; Vogel et al., 2012; Toriyama et al., 2017; Juriloff and Harris, 2018). Ceramides are
reported to regulate the generation and elongation of primary cilium (Wang et al., 2009; He et
al., 2014). Future studies will examine cellular metabolism in the early embryo and explore the

42

role of ceramides in regulating primary cilia during neural tube closure under high C2
conditions.
Prior work by several labs identified abnormal cell death as causative for NTDs
(Shimabukuro et al., 1998; Kamocki et al., 2013; Chang et al., 2015; Jazvinscak Jembrek et al.,
2015). Therefore, it was important to determine whether exposure to C2 during development
increased apoptotic activity within the neural tube. We employed the LysoTracker Red stain as
an early marker to visualize, count, and measure activated lysosomes. Previous studies showed
LysoTracker Red analyses as a comparable assay for areas of increasing apoptotic activity when
compared to TUNEL staining, perhaps marking apoptotic cells earlier (Fogel et al., 2012). We
observed no difference in the number of lysosomal punctae within the neural tube or throughout
the embryo (Figure 2.5 A-C), likely ruling out increased cell death as a potential cause for C2induced NTDs. Additionally, no increase in ROS generation within the neural folds was
observed as measured by DCF analysis, a noted difference when comparing P19 cells to
embryos. However, GSH Eh was significantly altered in embryos during the first 8 h after
exposure, with tissue GSH redox state recovering by 12 h (Figure 2.6). Therefore, an early,
acute change in cellular redox state was observed. Furthermore, since GSH Eh can be modified
through processes other than ROS production, one possible explanation is a period of redox
imbalance occurring in the first 8 h of exposure perturbs a developmental signaling pathway
important for neural tube closure, since ROS-mediated changes to redox state are not the only
means by which redox states are modified. Alterations to enzyme function, ATP availability and
metabolism may be manifested as changes to intracellular redox state and do not necessarily
occur as a consequence of ROS generation. This reasoning introduces and rationalizes many
different pathological and developmental outcomes where redox couple “circuits” are modified
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to alter cellular function and adaptation (Jones, 2008). Since redox states and related circuits are
the primary regulators of redox signaling, either conserved or pathologic (Schafer and Buettner,
2001), changes to redox state is of primary interest here. The observed shift in redox state in C2exposed embryonic tissue in the absence of ROS or cell death points to changes in cellular
functionality, signaling, processing, proliferation, and/or differentiation as potential factors
causing neural tube defects.
Finally, we noted a greater number of cranial defects in C2-treated embryos (Figure 2.10
D). Caudal defects were observed, but at a lower, not significant, frequency. The frequency of
cranial neural tube defects suggests anencephaly as a primary outcome (Carmichael et al., 2010),
and could be due to susceptible developmental periods, or due to different mechanisms of tube
closure cranially vs. caudally. Importantly, the increase in NTDs occurred with minimal impact
on other embryonic tissues, since embryo survivability, heart formation and function, growth rate
as measured by somite number (Figure 2.9 F), and other gross anatomical features, did not differ
between DMSO and C2-treated chick embryos.
To summarize, we observed C2-induced shifts in GSH Eh (a measure of redox state) in
treated embryos without a corresponding increase in apoptotic activity or ROS accumulation.
Notably, cell proliferation was lower. The direct role of ceramides in disrupting proper neural
tube closure is the focus of future planned experiments, which will more fully determine the
mechanism by assessing changes in tissue lipidomics, gene expression, and cellular function.
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CHAPTER 3: Embryonic Exposure to Ceramide, Fumonisin B1, and Valproic Acid
During Neural Tube Closure: A Toxicological Comparison in the Chick Embryo
Introduction
More than 300,000 infants are born with neural tube defects (NTDs) worldwide each
year. The neural tube (NT) is the first embryonic structure to form, during week 4 of human
development, later becoming the brain and spinal cord of the developing embryo. The NT
begins closing at the base of the hindbrain, extending anteriorly toward the face and posteriorly
toward to the back. Anterior defects most commonly result in anencephaly, a loss of skull bones
and brain matter, while posterior defects result in various forms of spina bifida, an opening or
protrusion of the spinal cord tissue in the lower back affecting spinal fluid regulation, bowel
control, and lower limb control. Several NTD-inducing compounds have been identified,
however the mechanism by which these environmental, pharmacological, and maternal toxicants
disrupt proper neural tube closure is unknown. This project aimed to compare three
developmental toxicants, known to cause NTDs, using the chick embryo. These compounds are:
C2-ceramide (C2), fumonisin B1 (FB1), and valproic acid (VPA).

Ceramides and Fumonisin B1
Ceramide is a bioactive sphingolipid comprised of a sphingosine backbone linked to a
fatty acid chain (Aburasayn et al., 2016). Ceramide synthesis occurs through several different
pathways including de novo, salvage, and sphingomyelin hydrolysis (see Figure 2.1 B). Previous
research in our lab identified C2 as a novel toxicant that increased risk of NTDs in exposed
chicken embryos (Ross et al., 2019). Circulating plasma ceramides are elevated in overweight
and obese individuals (Samad et al., 2006), creating a plausible link between the increased
frequency of infants born with NTDs to overweight and obese women, who are 2-3x more likely
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to have a baby with an NTD (McMahon et al., 2013; Huang et al., 2017). Interestingly, a potent
ceramide synthase inhibitor and corn mold byproduct, fumonisin B1 (FB1), has been associated
with an increased risk for NTDs in mothers who consume high quantities of contaminated food
(Gelineau-van Waes et al., 2009). Fumonisin B1 is a structural sphingoid analogue, acting to
competitively inhibit ceramide synthase function to reduce overall ceramide synthesis (He et al.,
2006). Studies indicate that as much as 25% of world crops are contaminated with FB1producing mold (Bullerman, 1996; Shephard et al., 1996). Contaminated corn has been
associated with several diseases in animals, including equine leukoencephalomalacia, rabbit,
lamb, and rat nephrotoxicity, and robust hepatotoxicity in most animal models evaluated
(Humphreys et al., 2001).
Studies have indicated that this inhibitory effect of FB1 on ceramide production is the
cause of NTD development (Wang et al., 1991; Constable et al., 2003) in both the chick
(Zacharias et al., 1996) and the mouse embryo (Marasas et al., 2004). The buildup of
metabolites (sphingosine and sphingonine) necessary for ceramide production has been reported
in affected embryos treated with FB1 (Zacharias et al., 1996; Marasas et al., 2004). Free
sphingoid bases are known to be cytotoxic and inhibit cell growth (Stevens et al., 1990).
Fumonisin B1 has also been shown to inhibit folate uptake by reducing concentrations of
sphingolipid, including ceramides, that are necessary for the GPI-linked folate receptor
functionality (Chatterjee et al., 2001).

Valproic Acid
While these toxicants have only been linked to NTDs in recent years, valproic acid
(VPA), a commonly prescribed antiepileptic medication (AEM), has been known to increase the
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risk for NTDs in offspring of mothers who take it during pregnancy for many years (Meadow,
1968). Epilepsy is a neurological disorder in which uncontrolled and unprovoked seizures occur
regularly. While there is no cure, AEMs are commonly prescribed to prevent seizures. Each
year in the United States, more than 25,000 babies are born to pregnant mothers who have
diagnosed epilepsy (Meador et al., 2008). This pharmaceutical teratogen increases the risk for
NTDs by 10-fold (Angus-Leppan and Liu, 2018; Wieck and Jones, 2018), while also increases
risks for cardiac malformations, growth retardation, hypospadias, microcephaly, and facial/digit
hypoplasia (Holmes et al., 2001; Bromley et al., 2010). Anticonvulsant medications are also
prescribed to individuals suffering from migraines, depression, social disorders, fibromyalgia,
and depression (Cascade et al., 2008), thus increasing the population of at-risk mothers.
Valproic acid is a wide-spectrum anticonvulsant medication that also carries moodstabilizing properties (Wlodarczyk et al., 2012). Studies have explored possible mechanisms of
VPA in various animal models, including zebrafish, xenopus, chick, rodents, dogs, and rhesus
monkeys (summarized in (Wlodarczyk et al., 2012). Proposed mechanisms of VPA-induced
NTDs primarily include 1) disruption of folate metabolism (Wegner and Nau, 1992) and 2)
inhibition of HDAC, leading to increased H3 acetylation (Gotfryd et al., 2011) or reduced Wnt
signaling (Eikel et al., 2006) in the developing embryo. However, sufficient evidence is lacking
to support either as the primary mechanism of action.

Comparing Toxicants
While many genetic factors have been linked to NTDs in humans and animal models,
they do not account for all cases. Environmental agents, including C2, FB1, VPA, and others
(Robert and Guibaud, 1982; Sadler et al., 2002; Groenen et al., 2003; Missmer et al., 2006;
Rasmussen et al., 2008; Chappell et al., 2009; Copp et al., 2013), disrupt proper development
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resulting in defects. Even more compelling may be the compounded risk of certain genetic
mutations and embryonic exposure to environmental toxicants. Therefore, a toxicological
comparison was conducted to determine whether similar or distinct pathways were disrupted in
embryos exposed to C2, FB1, or VPA, to identify cellular mechanisms responsible for NTDs.
This study is crucial to understand how environmental toxicants impede proper neural tube
closure, so future studies can identify genetic components that put babies at greater risk of NTDs
and develop preventative measures that work for one or all toxicants.
Methods
Generally, all methodology utilized for these experiments was described in Chapter 2
(pages 19-23). Therefore, previously described methods are summarized here, and new methods
are described in detail.

P19 Cell Culture
Undifferentiated P19 cells were cultured in alpha-modified MEM in an incubator at 37 °
C. Neuronal differentiation was initiated with 1 µM retinoic acid and cultured to form
aggregates from day 0-4, after which aggregates were collected and centrifuged. Pellets were
dissociated in trypsin and cells were seeded at density of 40,000 cells/cm2 on gelatin-coated
tissue culture dishes and cultured until treatment on day 7.

MDCK Cell Culture
Madin-Darby Canine Kidney (MDCK) cells were cultured in DMEM media with 10%
fetal bovine serum and 100 units/mL penicillin (Genesee), and 100 ug/mL streptomycin
(Genessee), in a humidified incubator gassed at 5% CO2, heated at 37 °C.
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Embryo Culture
Eggs were obtained from local suppliers, incubated at 37 °C for 30-36 hours to obtain
Stage HH6 embryos. Embryos were removed from the yolk using a filter paper disc and plated
on 6-well culture plates treated with C2-ceramide (C2), fumonisin B1 (FB1), and valproic acid
(VPA). Plates were placed in the incubator for up to 24 h.

Glutathione Redox Potential Analysis
Briefly, samples are collected in 5% perchloric acid containing 0.2 M boric acid (Sigma
Aldrich) and 10 μM γ-Glu-Glu, as an internal standard. Samples were centrifuged to pellet
protein and aliquots (300 μL) were derivatized. Aliquots (50 μL) were separated using a 3aminopropyl column (5 μM; 4.6 mm × 25 cm) and detection was obtained by fluorescence
monitoring with bandpass filters, 305–395 nm excitation and 510–650 nm emission. Quantitation
was obtained by integration relative to the internal standard. To calculate the GSH redox
potential (Eh), GSH and GSSG concentrations were used in the Nernst equation (Schafer and
Buettner, 2001).

DCF Reactive Oxygen Species Assay
2’7’-Dichlorofluorescin diacetate (DCF-DA) is a reporter molecule used to visualize the
generation of reactive oxygen species (ROS) in live cells or tissue. DCF-DA diffuses across lipid
membranes where the acetyl group is cleaved by intracellular esterases, sequestering the 2’7’dichlorofluorescin (DCF; Invitrogen) molecule within the cell. DCF is oxidized in the presence
of ROS to generate a fluorescent compound.
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P19 Cells
P19 cells were seeded at a density of 1 x 105 cells/well in a black with clear bottom 96well plate and incubated with 100 μM DCF-DA in PBS for 45 min. Cells were carefully washed
with PBS and then treated with different concentrations of C2 (6.25-800 µM). Results were
obtained using a fluorescence spectrophotometer with an excitation wavelength of 475 nm and
an emission wavelength of 525 nm.

Whole Embryo Culture
Embryos were incubated to HH8 and collected directly into a 5µM DCF-DA in 1x PBS
solution and incubated at room temperature for 20 min. Embryos were then rinsed twice in 1x
PBS and placed in a glass bottom cell culture dish with a control (0.5% DMSO in 1x PBS) or C2
(100 µM in 1x PBS) solution. To avoid bleaching of DCF fluorescence, embryos were imaged
over a 16-minute period. An initial image was collected using Olympus IX-81 LED microscopy
and CellSense; additional images were collected at the same settings at two-minute intervals for
16 min (9 images total). Relative percent change in measured DCF fluorescence was analyzed at
four locations in the neural folds in each image of the series using ImageJ Software.

Hanging Drop Assay
The assay was performed as described by Kim et al., 2000, with minor modifications.
Briefly, trypsinized MDCK cells were suspended at 2.5 × 105 cells/ml in DMEM (with 10%
FBS, 1% Penstrep) and C2 (100 µM), FB1 (100 µM), or VPA (600 µM). Cell suspension drops
(20 µL) were placed on the inner lid of a Petri dish and incubated for 0-4 h, and imaged at 0, 1,
2, 3, and 4 h. To image, drops were directly placed on a glass slide or triturated 10x through a
200 µL pipette and place don a glass slide. Three randomly selected areas of each drop were
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imaged at 4x on an upright microscope for non-triturated (n=3) and triturated (n=3) conditions
for each treatment. Cell aggregates were measured and binned according to size (Bin 1: clusters
1-10 cells, Bin 2: clusters 11-50 cells, or Bin 3: clusters>50 cells).

Mitochondrial Respiration Analysis
Briefly, stage 8 chick embryos were incubated for 12 h on 6-well agar plates, as
previously described, with 1xPBS, 0.5% DMSO, 100 µM C2, 100 µM FB1, or 600 µM VPA.
Embryos were collected and surrounding membranes removed in ice cold PBS. Respirometry
was measured via O2 consumption using the Oroboros O2K Oxygraph (Innsbruck, Australia).
Samples were collected in MiR05 respiration buffer and permeabilized at 37°C, followed by
respiration measurement by a modified substrate-uncoupler-inhibitor-titration protocol described
by Jheng et al., (2012). The chemical uncoupler carbonyl cyanide-4-(trifluoromethoxy)
phenylhydrazone (FCCP; 2.5 µM) was added to determine full electron transport system (ETS)
capacity. Following respirometry, embryo samples were collected from each chamber and
analyzed for total protein concentration.

Statistics
Data was analyzed using Microsoft Excel 2016 and Prism 7 software. A confidence
interval of 95% (α=0.05) was used as threshold for statistical significance. Data are presented as
mean ± SEM, with sample size (n) specified in the corresponding figure. P19 Cells. Statistical
significance was measured with Two-Way ANOVA and Dunnett’s multiple comparison tests
(MTT) or Tukey’s multiple comparison tests (GSH and DCF). Chick Embryos. Statistical
analysis was conducted with Two-Way ANOVA and Bonferroni (GSH, PH3, and LT) multiple
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comparison tests, Unpaired T-test (embryo length, somite number) or Kruskal-Wallace and
Welch’s t-tests (dose curve, NTD type).
Results

No Change in Cellular Viability and ROS Generation with VPA or FB1.
Undifferentiated P19 cells (n=3 for each treatment) were exposed to FB1 (0, 12.5, 25, 50,
100, 200, 400, or 800 µM) or VPA (0, 0.05, 0.1, 0.2, 0.4, 0.6, 0.8, 1.2, or 2.4 mM) for 24 hours
(n=4 at each dose tested; Figure 3.1 A-B). No significant decrease in viability was observed in
cells under any concentration of FB1 or VPA (Figure 3.1 A-B). Viability is known to be
reduced when concentrations exceed that of 100 µM C2 (page 24). Therefore, the working
concentrations of 100 µM C2, 100 µM FB1, and 600 µM VPA are accepted as non-lethal.
Initial analysis of C2 exposure showed an increase in reactive oxygen species (ROS)
generation in P19 cells with increasing concentrations (page 24). To determine whether FB1 and
VPA also induce oxidative stress, undifferentiated P19 cells were exposed to various
concentrations of FB1 (0, 25, 50, 75, 100, 150, or 200 µM) or VPA (0, 0.01, 0.75, 0.15, 0.3, 0.6,
or 1.2 mM). Relative fluorescence was measured using 2’7’-dichlorofluorescin diacetate and
compared to 1x PBS control. No difference in ROS generation with either treatment (Figure 3.1
C-D).
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Figure 3.1: Cell Viability and ROS Generation Unaffected in Cell Culture.
Undifferentiated P19 neural precursor cell viability was assessed to determine the toxicity of
fumonisin B1 (FB1) and valproic acid (VPA) on living cells. P19 cells were exposed to 0-800
µM FB1 or 0-2.4 mM VPA concentrations for 24 h (n=4). No significant change in viability was
observed in FB1 or VPA treated cells (A, B). ROS generation was unaffected under any
concentration of FB1 or VPA (C, D).
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P19 Neuronal Differentiation Affected by C2, but Not FB1 or VPA
We aimed to study whether C2, FB1, or VPA altered the ability of P19 cells to
differentiate. Neuronal differentiation is occurring at a rapid rate in the early neural tube and
brain during embryonic development. Therefore, undifferentiated P19 cells were treated with
retinoic acid on Day 0 (D0) to induce differentiation. Differentiating cells form aggregates
between D0-D4 and begin to express the protein β3-Tubulin (β3-Tub), a marker of microtubule
formation exclusive to neurons (Martellucci et al., 2019) and testis cells (Sullivan et al., 1986).
Cultures were treated with 1xPBS, 0.5% DMSO, 100 µM C2, 100 µM FB1, or 600 µM on D0,
0.5, 1, 1.5, 2, 2.5, 3, or 3.5 (n=3 for all treatments). Cellular aggregates were then imaged and
collected for β3-Tub analysis via Western Blot on D4 (Figure 3.2 A-C). Exposure to FB1 did
not alter β3-Tub expression (Figure 3.2 A, D). Expression of β3-Tub in VPA-treated samples
was decreased at D0 (p=0.0007), D0.5 (p=0.0019), D1 (p<0.0001), D1.5 (p<0.0001), D2
(p=0.00016), and D2.5 (p=0.0002), with normal expression at D3 and D3.5 (Figure 3.2 B, D)
C2-ceramide exposure resulted in reduced β3-Tub in samples treated at D0 (p<0.0001), D0.5
(p<0.0001), D1 (p<0.0001), D1.5 (p<0.0001), D2 (p<0.0001), D2.5 (p<0.0001), and D3
(p<0.0001), with normal β3-Tub expression by in samples treated at D3.5 (Figure 3.2 C, D).

Epithelial Adhesion is Altered with Ceramide Treatment
Madin-Darby Canine Kidney (MDCK) cells are an established epithelial model for
studying cellular adhesion. During neural tube closure, the neuroepithelium undergoes
significant morphological changes to produce a neural tube from a flat sheet of cells. To assess
whether adhesion is altered under treatment conditions, a hanging drop test was used. MDCK
cells were suspended in medium and treated with C2 (100 µM), FB1 (100 µM), or VPA (600
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Figure 3.2: P19 Neuronal Differentiation is Affected by VPA and C2.
P19 cells underwent neuronal differentiation for 4 days (D0-D4). β3-tubulin (β3-Tub)
expression was measured on D4 and normalized to control to determine effect on differentiation.
FB1 had no effect on neuronal differentiation (A, D). VPA reduced overall β3-Tub expression in
cells treated on D0 (p=0.0007), D0.5 (p=0.0019), D1.0 (p<0.0001), D1.5 (p=0.0005), D2
(p=0.0016), and D2.5 (p=0.0002), but had no effect on cells treated at D3 or D3.5 (B, D). C2
grossly reduced β3-Tub expression on D0 (p<0.0001), D0.5 (p<0.0001), D1.0 (p<0.0001), D1.5
(p<0.0001), D2 (p<0.0001), D2.5 (p<0.0001), and D3 (p<0.0001), with no effect on those cells
treated on D3.5. Asterisks indicate significance between VPA and PBS control (*= p≤0.05, **=
p≤0.01, ***= p≤0.001, ****= p≤0.00001). Carrots indicate significance between C2 and DMSO
control (^= p≤0.05, ^^= p≤0.01, ^^^= p≤0.001, ^^^^= p≤0.00001).
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Figure 3.3: MDCK Cell Adhesion Reduced with C2 Exposure.
The number of medium (10-50 cells) and large (>50 cells) aggregates was grossly reduced in
MDCK cells cultured with 100 µM C2 over 4 h. Both triturated and untriturated samples were
significantly affected (p<0.0001), while no difference was observed in cells treated with 600 µM
VPA. A significant difference was observed in cell aggregate formation under 100 µM FB1
treatment conditions at 1 h (p=0.0006), with recovery by 4 h. Asterisks indicate significance (*=
p≤0.05, **= p≤0.01, ***= p≤0.001, ****= p≤0.00001).
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µM). Twenty µL drops of cell suspension were incubated on the inner lid of a Petri dish and
imaged at 0, 1, 2, 3, or 4 h post treatment, with or without trituration. Clusters were counted and
binned based on the number of cells (Bin 1: 1-10 cells, Bin 2: 11-50 cells, or Bin 3: >50 cells).
The data revealed that cell adhesion was significantly reduced in both triturated (p<0.0001) and
untriturated (p<0.0001) MDCK cells exposed to 100 µM C2 after 4 h (Figure 3.3 A, B). FB1
reduced aggregate formation in non-triturated samples at 1 h (p=0.0006), with recovery by 4 h
(Figure 3.3 C). No effect was observed under triturated conditions. Cells cultured with VPA
showed no difference in adhesion when compared to PBS control in either treatment group
(Figure 3.3 C, D).

Morphological Defects in Chick Embryos
Understanding that cell viability was predominantly unaffected in cell culture treated
with various concentrations of C2, FB1, and VPA, we moved to the chick embryo model to
assess effects of the toxicants during neural tube closure.
Using the EC culture method, as previously described in Chapter 2, we incubated HH8
chick embryos on 6 well agar plates with 1x PBS, and varying concentrations of fumonisin B1
(FB1; 50 µM, 100 µM, or 200 µM), or valproic acid (VPA; 300 µM, 600 µM, or 1.2 mM) for 24
h. Morphological and histological analysis was conducted to confirm neural tube defects
(NTDs). Both cranial and caudal defects were observed across treatment groups and
concentrations (Figure 3.4 A-D). The frequency of NTDs increased as the concentration of each
toxicant increased (Figure 3.4 F,G), with penetrance rates of 42% with 50 µM FB1 (n=12), 50%
with 100 µM FB1 (n=12; p=0.0422), 100% with 200 µM FB1 (n=12; p=0.0179), 40%
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Figure 3.4: Observed Defects in Treated Embryos.
Affected embryos exposed to 100 µM fumonisin (FB1) or valproic acid (VPA) developed cranial
and caudal defects like what is observed in human embryos with neural tube defects. Normal
embryonic growth was observed in control embryos (A). Cranial defects included minor as well
as more severe defects, including failed anterior neuropore closure (B) or neural fold fusion (C).
Caudal defects like that shown in D and E were commonly observed in affected embryos (somite
formation was unaffected at the level of the open folds). F. Fumonisin Dose Curve. Twenty-four
hour incubation of chick embryos on control (1x PBS) or FB1-containing (50 µM, 100 µM, or
200 µM) agar plates resulted in increased NTD frequency at 100 and 200 µM doses. Control
embryos experienced a NTD frequency of 6%, while exposure to 50 µM FB1 resulted in a 42%
NTD frequency, 100 µM FB1 increased to 50%, and 100 µM FB1 resulted in 63% NTDs. 100
µM and 200 µM FB1-induced NTD rates were statistically significant when compared to control
(p=0.0422, p=0.0179). G. Valproic Acid Dose Curve. Chick embryos were incubated as
described in I, on control or VPA-containing (300 µM, 600 µM. 1.2 mM or 2 mM) agar plates.
Five percent of control embryos had NTDs. The rate of NTDs increased to 40% at 300 µM
(p=0.0256), 69% at 600 µM (p=0.0004), 76% at 1.2 mM (p<0.0001), and 100% at 2.0 mM
(p<0.0001) of exposed embryos. All doses resulted in a significantly increased risk for NTDs.
Asterisks indicate significance (*= p≤0.05, **= p≤0.01, ***= p≤0.001, ****= p≤0.00001).
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penetrance with 300 µM VPA (n=15; p=0.0256), 69% penetrance with 600 µM with VPA
(n=18; p=0.0004), 76% with 1.2 mM VPA (n=17; p<0.0001), and 100% with 2.4 mM (n=6; p
<0.0001). A histological analysis to confirm presence and type of NTD type was conducted.
Neural tube defects were categorized as cranial, caudal, and cranial + caudal defect, depending
on location within the embryo. Cranial defects occurred anywhere between the anterior
neuropore and the 10th somite, caudal defects between the 11th somite and posterior neuropore,
and cranial + caudal defects were embryos with a defect in both region. Analysis of NTD type
revealed no significant difference observed across treatments (data not shown).
Somite pairs develop bilaterally from anterior to posterior along the neural tube,
beginning just below the otic region. Total number of somites at the time of collection before
and after treatment were counted for embryos as in Ross et al., (2019), with further analysis to
compare the number of somite pairs that developed in unaffected embryos (those without NTDs)
and affected embryos (those with NTDs; Figure 3.5 A-D). Normal ceramide treated embryos
developed 14.7 somite pairs (n=20; p=0.8977) and did not differ when compared to normal
DMSO-treated embryos, who developed an average of 14.63 somites (n=19). Those embryos
exposed to DMSO or C2 with NTDs developed 14.78 (n=9) and 14.05 (p=0.3751) somite pairs,
respectively. Control PBS-treated embryos developed an average of 16.06 somite pairs (n=35).
Normal embryos exposed to 600 µM VPA developed 15.89 pairs (n=18; p=0.8252), and those
with NTDs developed 14.40 pairs (n=5; p=0.0698). Fumonisin B1 reduced the number of somite
pairs developed in normal embryos to 12.57 (n=14; p<0.0001) and affected embryos to 12.86
(n=7; p=0.0017).
Embryo development is associated with both structural development and overall growth.
We assessed the rate of growth of control and treated embryos, as measured by cranial to caudal
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Figure 3.5: Somite Development and Embryo Growth.
The number of somite pairs each affected (NTD) or normal (no NTD) embryo developed during
24 h incubation with C2 (100 µM), FB1 (100 µM), or VPA (600 µM) was compared to control
(0.5% DMSO or 1x PBS). Normal and affected embryos treated with FB1 developed
significantly fewer somites (p<0.0001, 0.0017 respectively) when compared to control (C, D).
No difference in somite pair developed was observed in normal or affected C2 or VPA treated
embryos (A-D). Embryo length (cranial-caudal) differed in C2 treated affected embryos
(p=0.0013; F). FB1-treated embryos were significantly shorter with (p=0. 0449; G) or without
NTDs (p=0.0115; H). Embryos exposed to VPA were significantly longer than control (0.0057;
G). Asterisks indicate significance (*= p≤0.05, **= p≤0.01, ***= p≤0.001, ****= p≤0.00001).
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length and somite pair development after 24 h incubation (Figure 3.5 E-H). Control PBS-treated
embryos grew an average of 6.08 mm (n=35). Embryos exposed to 100 µM FB1 that were
normal (no NTD) grew an average of 5.28 mm (n=14; p=0.0013), and those with NTDs grew an
average of 5.314 mm (n=7; p=0.0115). Normal embryos exposed to 600 µM VPA grew 7.14
mm (n=4; p=0.0057). NTD-affected embryos exposed to VPA grew 5.71 mm (n=5; p=0.2793).
DMSO-treated embryos without NTDs grew an average of 5.57 mm (n=18), while those
with NTDs grew an average of 5.44 mm (n=10). Those embryos exposed to 100 µM C2 that
developed normally grew an average of 5.66 mm (n=20; p=0.9263). C2-treated embryos with
NTDs grew only 4.93 mm (n=18; p=0.0479).

Cellular Proliferation Unaffected, While Cell Death is Increased in Chick Embryos
To determine whether FB1 or VPA altered cell proliferation or death in treated embryos,
we analyzed phospho-histone 3 (PH3) and activated lysosomal (LysoTracker Red; LT),
respectively.
To assess proliferation, stage 8 chick embryos were incubated on FB1 or VPA agar plates
for 24 h and stained with PH3 antibody. Embryo (n=2-4) sections were grouped into five
regions of interest: Head, Otic, Upper Spinal Cord (USC), and Lower Spinal Cord (LSC), and
caudal. The count, total and within the neural tube, of PH3+ cells were measured for each
section and recorded. As visualized in Figure 3.6 and Table 3.1, most regions showed a
statistically significant reduction in PH3+ cell after FB1 and VPA exposure, with variability
across sections and embryos. Total PH3+ cell count (Figure 3.6 B) was significantly less in both
treatment groups when compared to control in all groups: Head (p<0.0001, p=0.002), Otic
(p<0.0001, 0.0037), USR (p<0.0001, both), LSR (p=0.0001; p=0.0002), and Caudal (p=0.0002;

61

Figure 3.6: Embryonic Cell Proliferation is Downregulated with FB1 and VPA Exposure.
Expression of PH3 was evaluated in embryo sections to determine proliferation, both within the
neural tube (A) and the entire section (B). No significant difference was observed in the number
of PH3+ cells within the neural tube across treatments (A). However, the number of PH3+
positive cells in the whole section of each region of the embryo was significantly reduced in
VPA- and FB1- treated embryos. Asterisks indicate significance between VPA and PBS control
(*= p≤0.05, **= p≤0.01, ***= p≤0.001, ****= p≤0.00001). Carrots indicate significance
between FB1 and PBS control (^= p≤0.05, ^^= p≤0.01, ^^^= p≤0.001, ^^^^= p≤0.00001).
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Table 3.1: Comparison of Embryonic Cellular Proliferation with PBS, FB1, or VPA Treatment.
Tissue sections were analyzed for PBS-, FB1-, and VPA-treated embryos to obtain PH3+
(marker for M phase) cell counts. Sections were grouped by region based on location along the
A-P axis in five groups: Head, Otic, Upper Spinal Cord (USC), Lower Spinal Cord (LSC), and
Caudal. Due to high variability, an average PH3+ cell count is reported for all sections and an
average within the neural tube (NT). Significance was observed in total count for the section
across treatments and regions, however no significance was observed in count for neural tube.
Significant P values bolded.
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Punctae
Figure 3.7: Valproic Acid Increases Cellular Apoptosis in Treated Embryos.
Analysis of acidic lysosomal staining in PBS, 100 µM FB1 or 600 µM VPA treated embryos
(n=2-3 per treatment) was performed to determine whether cell death was increased globally or
within the neural tube. Increased total punctae staining (p<0.0001), as well as punctate within
the neural tube (p=0.0002) was observed when VPA was compared to both PBS and FB1. No
significant difference was observed in FB1 treated embryos when compared to control.
Asterisks indicate significance (*= p≤0.05, **= p≤0.01, ***= p≤0.001, ****= p≤0.00001).
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p<0.0001). The number of proliferating cells within the NT was decreased in VPA treated
embryos when compared to control in the Head (p=0.0185), but not in any other group (Figure
3.6 A). Proliferation was decreased in the NT of embryos treated with FB1 in the Head
(p<0.0001), Otic (p=0.0203), and USR (p=0.034) when compared to control. Ceramide
treatment showed a global reduction in cell proliferation (page 28). LysoTracker Red (LT), was
used to visualize activated lysosomes, a marker for cell death, in embryos cultured in PBS
control (n=2) and FB1 (n=3) or VPA (n=3) for 24 h. The number of LT punctae were quantified
in histological sections (Figure 3.7). When comparing treatments to control, no difference was
observed in the overall number of LT-positive acidic lysosomes in FB1-treated embryos. VPA
induced significantly more LT-positive staining, both within the NT (p=0.0002) and globally in
the embryo (p<0.0001) when compared to control and FB1. Cranial vs. caudal sections and open
vs. closed neural tubes also showed no difference (data not shown).

Glutathione Redox Potential in Chick Embryos is Altered Differentially in Response to C2, FB1,
and VPA Treatment
Chick embryos (HH8) were cultured with 100 µM FB1 or 600 µM VPA for 24 hours.
Samples were collected at 0, 1, 2, 4, 6, 8, 12, or 24 h and assessed for glutathione (GSH) redox
potential (Eh) utilizing HPLC analysis.
Glutathione redox potential significantly and differentially affected in the chick embryo
under FB1 and VPA treatment. Fumonisin B1 exposure resulted in a significant shift to a more
reduced tissue redox state in samples collected at 1 h (p=0.0452), 4 h (p=0.0011), 8 h
(p<0.0001), and 12 h (p<0.0001), with recovery to a normal state by 24 h (Figure 3.8A).
Samples at 2 h were also more oxidized, but not significant (p=0.1148). This shift appears to be
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Figure 3.8: Embryonic Glutathione Redox Potential Analysis 24 hours.
A. The glutathione (GSH) redox potential (Eh) of chick embryos exposed to FB1 (100 µM) was
significantly reducing when compared to that of control at 1 h (p=0.0452), 4 h (p=0.0011), 8 h
(p<0.0001), and 12 h (p<0.0001). B. The tissue of VPA (600 µM) exposed embryos was
significantly more reduced at 1 h (p=0.0004) and 2 h (p=0.0182), then the tissue becomes more
oxidized at 4 h (p=0.0051) and 8 h (p=0.0233). Carrots indicate significance between FB1 and
PBS control (^= p≤0.05, ^^= p≤0.01, ^^^= p≤0.001, ^^^^= p≤0.00001). Asterisks indicate
significance between VPA and PBS control (*= p≤0.05, **= p≤0.01, ***= p≤0.001, ****=
p≤0.00001).
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an opposite response when compared to embryonic tissue exposed to C2, where an oxidizing
shift was observed between hours 1-8 post treatment (Ross et al., 2019). Valproic acid-exposed
embryos resulted in an initial shift to a more reduced state at 1 h (p=0.0039), with a shift to a
more oxidized state at 4 h (p=0.0402), when compared to control (Figure 3.8 A).

Cellular Redox State is Grossly Affected by C2 Exposure, but Not FB1 or VPA
We previously reported that while the cellular redox state of undifferentiated P19 cells
was unaffected, that of neuronally differentiated cells was significantly oxidized in response to
C2 (100 µM) treatment (Ross et al., 2019). Therefore, we similarly treated P19 cells with FB1
(100 µM) or VPA (600 µM) to determine the individual effects of these drugs on the cellular
redox state of P19 cells under each condition (undifferentiated or differentiated; n=2-3 for all
treatments). The cellular redox state of undifferentiated cells was unaffected when exposed to
FB1 (Figure 3.9 A). However, VPA induced an oxidizing shift in the GSH Eh at 1 h (p<0.0001),
2 h (p<0.0001), 4 h (p<0.0001), 6 h (p=0.0001), 8 h (p=0.0002), 12 h (p<0.0001), and 24 h
(p<0.0001; Figure 3.9 B).
Differentiated P19 cell exposure to VPA resulted in a more oxidized GSH Eh at 1 h
(p=0.0379) and 24 h (p=0.0466), while exposure to FB1 resulted in an oxidizing shift in the GSH
Eh at 24 h (p=0.0301). The GSH Eh was not significantly different at any other time point under
either treatment condition (see Figure 3.9 C, D). These redox potential shifts under VPA and
FB1 treatments indicate a differential response in the tissue when compared to all treatments.
Mitochondrial Functionality was Altered in Embryos Exposed to C2, but Not FB1 or VPA
To determine whether these shifts in tissue redox state were a result of toxicant-induced
mitochondrial dysfunction, embryos were cultured on drug agar plates treated with 1x PBS,
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DMSO (0.5%), C2 (100 µM), FB1 (100 µM), or VPA (600 µM) for 12 h before collected and
analyzed for mitochondrial respiration using the Oroboros O2K oxygraph (n=3, with 4-5
embryos pooled per sample). Respiration was measured as oxygen (O2) flux at full uncoupling
with FCCP and compared to control. Mitochondrial respiration was unaffected by VPA
treatment when compared to PBS control, while FB1 caused a slight reduction in overall O2 flux
(Figure 3.10). C2 exposure increased O2 consumption when compared to DMSO control
(p=0.0207).
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Figure 3.9: Cellular Glutathione Redox Potential Analysis 24 hours.
The glutathione (GSH) redox potential (Eh) of undifferentiated P19 cells was unaffected by FB1
exposure over 24 h (A). Treatment with VPA resulted in a significantly oxidizing shift in the
redox potential of undifferentiated P19 cells from 1-24 h (B). Neuronally differentiated P19
cells were unaffected by FB1 until 24 h, where the GSH Eh became more oxidized (C).
Similarly, an oxidizing shift in the GSH Eh was observed at 2 h and 24 h in differentiated P19
cells treated with VPA (D). Asterisks indicate significance between VPA and PBS control (*=
p≤0.05, **= p≤0.01, ***= p≤0.001, ****= p≤0.00001). Carrots indicate significance between C2
and DMSO control (^= p≤0.05, ^^= p≤0.01, ^^^= p≤0.001, ^^^^= p≤0.00001).
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Figure 3.10: Embryonic Mitochondrial Respiration is Increased by C2-ceramide.
Chick embryos were exposed to 100 µM C2, 100 µM FB1, or 600 µM VPA for 12 hours and
collected for mitochondrial respirometry (n=3, with 4-5 embryos pooled per sample). Oxygen
(O2) flux was measured after full uncoupling following the addition of FCCP and normalized to
control. Respiration was unaffected by VPA and FB1 when compared to PBS control, but
increased in C2-treated embryos when compared to DMSO control (p=0.0207). Graphs
represent comparison to normal flux of 100%. Asterisks indicate significance (*= p≤0.05, **=
p≤0.01, ***= p≤0.001, ****= p≤0.00001).
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Discussion
This study was designed to compare three neural tube defect (NTD)-inducing toxicants
using the chick embryo to determine whether similar or differential mechanisms were employed
to result in the same defect. Presently, the only effective pre-treatment known to reduce the risk
for NTDs is pre- and perinatal consumption of folic acid (FA). While effective in reducing NTD
frequencies by up to 70%, there are still thousands of cases each year in which FA is ineffective
and babies are born with these life-threatening defects.
A comparative analysis such as this one employs an inexpensive model to evaluate the
effects of environmental and pharmaceutical toxicants during development. We confirmed that
while working concentrations were not cytotoxic and did not induce reactive oxygen species
(ROS) (Figure 3.1), an increased number of NTDs occurred in embryos exposed to C2-ceramide
(C2), fumonisin B1 (FB1), and valproic acid (VPA) (Figure 3.4). Morphological analysis
revealed that FB1 exposure retarded overall growth (as measured by embryo length) and somite
pair development in both affected and normal embryos (Figure 3.5 C, D, F, G). C2 also reduced
the number of somite pairs that formed in embryos with NTDs (Figure 3.5 F). Interestingly,
normal embryos exposed to VPA grew significantly longer than control embryos (Figure 3.5 G).
We explored various cellular responses to determine whether these differential responses were
also observed in other readouts, including cellular differentiation, adhesion, death, proliferation,
redox state changes, and mitochondrial respiration.
As the neural tube closes, epithelial modifications and adhesions are required to unite and
fuse the neural tube and non-neural ectoderm, resulting in an enclosed structure. We examined
the effects of C2, FB1, and VPA on MDCK cell ability to form and maintain tight adhesions.
While FB1 and VPA had no effect, C2 significantly reduced the number of aggregates that
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formed (both with and without trituration), suggesting this lipid molecule may reduce cellular
adhesion within the neural tube. In recent years, experimental misexpression of tight junction
proteins, including claudins (Baumholtz et al., 2017), has been linked to increased frequency of
NTDs, indicating the formation and maintenance of these tight bonds is critical for proper neural
tube closure.
As the neural tube is closing the embryo undergoes rapid growth, during which cellular
proliferation, differentiation, apoptosis, and metabolic activities are orchestrated within strict
boundaries. To model neuronal differentiation, like that occurring in the neural tube, a P19
embryonic carcinoma cell line used. Data revealed significant reduction in differentiation, as
measured by β3-tubulin expression, by C2 and VPA exposure in the early stages of
differentiation (D0-D2.5; Figure 3.2). Evaluation of metabolic function under toxicant exposure
revealed a reduction in overall mitochondrial respiration in response to FB1 and C2 (Figure 3.9).
Oxidative stress and cell death are often a result of poor mitochondrial respiration.
Therefore, we examined glutathione (GSH) redox potential (Eh) as a readout for tissue redox
state. Undifferentiated and differentiated P19 cells were exposed to C2, FB1, or VPA for up to
24 h and collected for GSH Eh analysis. The GSH Eh of undifferentiated cells underwent an
oxidizing shift at each time point from 1-24 h in response to VPA exposure, but not FB1 (Figure
3.8 B) or C2 (Figure 2.3 A). Once differentiated, P19 cells exposed to C2 undergo an oxidizing
shift in the redox state (Figure 2.3 B), however FB1 had no effect until 24 h (Figure 3.8 C). VPA
caused an oxidizing shift at 2 h and 24 h, but it was not sustained at intermediate timepoints
within the treatment window.
In the embryo, a different response was observed in the GSH Eh. Embryos treated with
FB1 experienced reducing stress from 1-12 h, followed by recovery to a normal state. VPA
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induced an initial oxidizing shift at 2 h, followed by a reducing shift in the redox state at 4 h and
recover to normal by 8 h (Figure 3.8 A). This differential response in a controlled P19 cell line
and a complex embryo is not a novel finding, as C2 displayed an oxidizing shift in the embryo
from 1- 8 h, followed by a recovery to normal. However, P19 GSH Eh in differentiated cells
became oxidized later (24 h). An examination of cellular apoptosis, measured by activated
lysosomes, revealed an increased in overall cell death in VPA-treated embryos (Figure 3.7). C2
and FB1 exposure did not result in greater cell death. However, overall cellular proliferation was
reduced across treatments (Figure 3.6).
This unique response in the redox state of embryos treated with C2, FB1, or VPA may be
the result differential protein modification, resulting in downstream effects (genetic, functional,
or biochemical) that can lead to disrupted neural tube closure. Every protein has a redox
midpoint (Timme-Laragy et al., 2013). If a reducing or oxidizing shift, like those observed in
FB1- or C2-treated embryos, occurs during critical windows of development, proteins may be
modified as a result. These modifications be they genetic, functional, or biochemical, lead to
disrupted neural tube closure.
In short, at least one differential response was observed in each analysis, suggesting that
when considering developmental toxicology and the resulting defects, a “one size fits all”
mechanism in NTD formation is unlikely. Environmental and maternal toxicant or
pharmaceutical exposures may vary globally, putting certain groups at greater risk for having
children with these devastating and expensive defects. Therefore, it is imperative that
descriptive analyses, such as this, be performed to better understand toxicological effects on cells
and tissues throughout development to develop better preventative measures.
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Future studies should aim to include additional toxicants known to induce NTDs,
including heat, retinoic acid, and hyperglycemia, to expand the current understanding for each of
these teratogens. RNA-sequencing may reveal changes in gene regulation in response to specific
mechanisms explored here, or lead to the identification of additional assays to broaden our
knowledge about these toxicants. These studies will inform scientific and medical professionals
on the best approaches to reduce the risk for NTDs in prospective mothers.
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CHAPTER 4: Gene Expression Changes in Response to Developmental Toxicants
Known to Induce Neural Tube Defects: A Comparison of RNASequencing Profiles of Chicken Embryos Treated with
C2-Ceramide, Fumonisin B1, and Valproic Acid
Introduction
The early embryo begins as a flat sheet of cells that thickens and raises bilaterally along
the AP axis. These ridges undergo mechanical bending to unite at the hindbrain and adhere
dorsally from head to tail to generate the enclosed neural tube (NT). In the chick embryo, these
structural changes occur within 50 hours of fertilization. The orchestration of these cellular
changes during development relies on time- and cell-specific gene expression. RNA sequencing
technologies have advanced significantly over the last decade, providing an invaluable tool to
identify gene expression profiles throughout development. This has allowed scientists to better
understand how genetic mutations negatively impact embryo growth and morphology.
More than 300 genes have been linked to failed NT closure during early development,
resulting in neural tube defects (NTDs) in the mouse model (Harris and Juriloff, 2007; Harris and
Juriloff, 2010; Juriloff and Harris, 2018). RNA sequencing projects have evaluated specific gene
families, localized gene groups, and transcriptomic changes in affected human and mouse
models (Gustavsson et al., 2008; Krupp et al., 2012; Dong et al., 2016; Yu et al., 2017; Kindt et
al., 2018) Many of these genes are involved in key developmental processes such as cell polarity,
division, migration, proliferation, patterning, metabolism, and nutrient transport. In human
pregnancies, if one child is affected with a NTD, the rate of risk for siblings is 2-5%
(Rampersaud et al., 2006). However, the evidence pointing to genetic mutations as the primary
source of these congenital defects is minimal, suggesting that multifactorial conditions lead to
failed NT closure.
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Gene regulation can be altered by more than mutations. Environmental toxicant exposure
during development can up- or down-regulate the expression of genetic information. Previous
studies in our lab have compared three different teratogens, or developmental toxicants, known
to induce NTDS: C2-ceramide (C2), fumonisin B1 (FB1), and valproic acid (VPA). We
characterized several differential responses in embryos exposed to each toxicant (summarized in
Table 4.1). Therefore, to determine whether C2, FB1, and VPA differentially alter gene
regulation, RNA-sequencing is necessary.

Methods

Embryo Culture
As described in Chapter 2, fertilized chicken eggs were obtained from local vendors and
incubated at 38.5°C for 28-32 h to Hamburger & Hamilton (HH) stage 8. Embryos were
collected using the early chick (EC) culture method described Chapman et al. (2001). Briefly, an
egg was cracked into a petri dish, thick albumin was removed using a Kimwipe so a filter paper
disc could be placed around the embryo. The embryo was then cut from the vitelline membrane
and suspended embryo from the yolk. A second filter paper disc was placed on the ventral side
to create a sandwich. Embryos were subsequently plated on control or drug treated six-well agar
plates (as described below). Embryos were incubated on the plates for a specified time before
being removed into fresh 1x PBS for imaging.

Embryo Plate Preparation
Embryos were collected as described in Chapter 2 (page 20). Briefly, stage 8 chick
embryos were collected from the yolk using a filter paper disc, then placed on drug or control
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plates and incubated at 37 °C for 6 h. 6-well plate preparation for chicken embryo culture was as
follows:

Drug Plate
A stock solution was made for each drug: C2 (Cayman Chemical) stock solution of 20.91
mM (1 mg/140 μL DMSO), FB1 (Cayman Chemical) stock solution of 20 mM (1 mg/67 µL
1xPBS), or VPA (Sigma-Aldrich) stock solution of 40 mM (1mg/150 µL 1xPBS). Each stock
solution was diluted in 2 mL 1%BSA/PBS with PenStrep (1:1000) to working solution
concentrations: 100 µM C2, 100 µL FB1, and 600 µL VPA. 6 mL thin albumin was added,
followed by 6 mL agar (0.18 g BactoAgar in 6 mL saline) to produce 14 mL homogenized drug
solution. 2 mL of the solution was added to each well of a 6 well plate and refrigerated to
solidify.

Control Plate
70 µL Dimethyl Sulfoxide (DMSO; Millipore) or 70 µL 1xPBS was added to 2 mL
1%BSA/PBS with PenStrep (1:1000). 6 mL thin albumin was added, followed by 6 mL Agar
(0.18 g BactoAgar in saline) to produce 14 mL homogenized drug solution. 2 mL of the solution
was added to each well of a 6 well plate and refrigerated to solidify.

RNA Extraction
Embryos (n=3 per treatment) were cultured on 6 well plates treated with C2, FB1, VPA,
DMSO, or PBS for 6 h prior to being removed from surrounding membranes in ice cold 1xPBS
before being collected into 200 µL Trizol (Zymo Research). Samples were placed in the freezer
overnight before RNA extraction was performed using Direct-zol RNA Miniprep kit (Zymo
Research). RNA integrity was assessed using a Bioanalyzer 2100 (Agilent Technologies). RNA
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(1.5 mg) from each sample was converted to mRNAseq library at the CvDC RNA Expression
Core using Illumina Tru-seq kit (Illumina) and sequenced via Rapid Mode on a HiSeq 2500
(Illumina). Using Novalign (Novacraft Technologies) sequences were aligned to gallus gallus
genome GRCg6a. Differential expression between drug and control groups (C2 v DMSO; FB1
and VPA v PBS) at 6 h post-treatment using the DSeq package in R Studio.
Results

Differentially Expressed Genes in Response to C2, FB1, or VPA Exposure in the Chick Embryo
Embryos were incubated on 6 well agar plates with 1x PBS, DMSO (0.5%), C2 (100
µM), FB1 (100 µM), or VPA (600 µM) for 6 h, a timepoint specifically chosen based to capture
the earliest changes in gene expression, rather than downstream gene-regulatory events.
Individual embryos (n=3 per treatment) were then collected for RNA extraction and analysis.
Sample libraries were combined by treatment and compared to control for expression analysis.
There were 9,417, 8,939, and 10,873 genes measured in library C2 vs DMSO, FB1 vs PBS, and
VPA vs PBS, respectively. A GO analysis was performed to classify the genes. No significant
differences were observed across treatment groups.

Genes of Interest from C2 vs DMSO Library
The expression of 16 differentially expressed genes (DEGs) was reported as significantly
altered in the C2 vs DMSO library. A significant reduction in the expression of 11 of these
DEGs and significant overexpression of 5 DEGS is summarized in Table 4.1. The 11
downregulated DEGs include TXNIP, GNAO1, DDIT4, PRKAR1β, DNAH10, TERB1, LRRC8B,
CKB, ADNP2, and 2 novel genes. Those DEGs upregulated under C2 conditions include
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SLC38A2, DNAJC12, SLC6A6, CAB39L, and one novel gene. Those genes of initial interest
include TXNIP, DDIT4, ADNP, CKB, and SLC38A2.
Thioredoxin interacting protein (TXNIP) expression is significantly downregulated in
embryos exposed to C2. TXNIP is a stress-induced regulator of cellular metabolism and
thioredoxin antioxidant activity, including thioredoxin (Trx) 1 and 2 (Shalev, 2014). Under
stressful oxidative conditions, TXNIP moves from the nucleus to the mitochondria where it can
oxidize Trx 2, leading to cellular apoptosis (Saxena et al., 2010). One study reported decreased
expression or KO of TXNIP led to reduced cellular respiration, shifting mitochondrial function
from oxidative phosphorylation towards anaerobic glycolysis (Yoshioka et al., 2012). We
observed that embryonic redox state was significantly oxidized (page 31) and mitochondrial
respiration was negatively impacted by C2 treatment (page 67). Further study is necessary to
determine whether TXNIP is responsible for these activities, and whether it is directly or
indirectly regulated by ceramide exposure.
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Table 4.1: Gene Table of Significant DEGs from Ceramide vs DMSO RNA-seq Library
Expression of 16 genes was significantly altered in embryos exposed to C2-ceramide when
compared to DMSO control. Expression of 11 DEGs was reduced (above bolded line), while 5
DEGs were overexpressed.

Ensembl Gene ID

Gene
Name

ENSGALG00000005957

Novel

ENSGALG00000048409
ENSGALG00000003163
ENSGALG00000041459

TXNIP
GNAO1
DDIT4

ENSGALG00000003675

PRKAR1B

ENSGALG00000006644

Novel

ENSGALG00000043806

DNAH10

ENSGALG00000005214

TERB1

ENSGALG00000006167
ENSGALG00000011511
ENSGALG00000035669

LRRC8B
CKB
ADNP2

ENSGALG00000008497

SLC38A2

ENSGALG00000052593
ENSGALG00000002769

Novel
DNAJC12

ENSGALG00000006425
ENSGALG00000017005

SLC6A6
CAB39L

Gene Product
Solute carrier family 6 member
14
Thioredoxin interacting protein
G protein subunit alpha o1
DNA damage inducible
transcript 4
Protein kinase cAMP-dependent
type I regulatory subunit beta
Acyl-CoA synthetase long-chain
family member 6
Dynein axonemal heavy chain
10
Telomere repeat binding bouquet
formation protein 1
Uncharacterized LOC107056693
Creatine kinase B
ADNP homeobox 2
Solute carrier family 38 member
2
DnaJ heat shock protein family
(Hsp40) member C12
Solute carrier family 6 member 6
Calcium binding protein 39 like
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2-Fold
Change

P-value

Padj

-1.89351

0.000274

0.044299

-1.61687
-1.40904
-1.28995

2.66E-10
0.000125
0.00016

7.43E-07
0.029876
0.033579

-1.22499

1.26E-06

0.001174

-1.2216

0.000144

0.032663

-1.14354

1.65E-05

0.006943

-1.08862

0.000123

0.029876

-1.04765
-1.028
-1.02009

2.52E-06
3.19E-07
3.98E-08

0.001763
0.000383
8.35E-05

1.038126

5.74E-15

4.82E-11

1.081337
1.084619

0.000142
9.75E-05

0.032663
0.026404

1.231983
1.349427

6.06E-12
6.99E-06

2.54E-08
0.004188

DNA damage inducible transcript 4 (DDIT4) is a known mTOR repressor. DDIT4 has
been implicated in neuronal differentiation and is generally upregulated in response to cellular
responses, including heat shock (Wang et al., 2003), radiation (Ellisen et al., 2002), hypoxia
(Shoshani et al, 2002), and energy stress (Sofer et al., 2005). Endoplasmic reticulum stress
(Wang et al., 2003) and glucocorticoids (Molitoris et al., 2011) are also known to upregulate
DDIT4. Conversely, Gordon et al., (2016) reported DDIT4 is downregulated in response to
resistance exercise, nutrient consumption, mTOR suppression, and testosterone. Decreased
DDIT4 expression is also associated with reduced expression of pluripotent genes, including
Oct4, Klf4, and Nanog (Gharibi et al., 2016).
Activity-dependent neuroprotective protein (ADNP) is a transcription factor associated
with neuronal differentiation, cell growth regulation, and has been characterized in the neural
tube in the mouse embryo, and when knocked out results in cranial NTDs (Pinhasov et al., 2003).
ADNP is necessary for proper neural tube closure, regulating genes such as Wnts (Sun et al.,
2020), Oct4 and Pax6, and is associated with neurogenesis, organogenesis, and lipid transport
(Mandel et al., 2007).
Less is known about CKB and SLC38A2. However CKB has been characterized in
highly oxidative tissues as a catalyst for transferring phosphates from ATP to creatine, and is
known to be expressed in the brain of embryos (Roy et al., 2013). This suggests a possible link
to reduced respiration in C2-treated embryos. SLC38A2 or SNAT2 is a solute transporter found
in embryonic stem cells associated with the uptake of nutrients necessary for differentiation (Tan
et al., 2016).
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Genes of Interest from FB1 vs PBS Library
In the FB1 vs PBS library, 20 DEGs were significantly over (15 genes) or under (5 gene)
expressed (see Table 4.2). Under FB1 treatment, the expression those significantly upregulated
DEGs include PTBP2, PAPD7, UTP15, IRX3, PLAA, IPO11, ZFAND5, DMXL1, DIMT1,
CERT1, TRIM23, RPPL25L, FST, SLC6A6, and 1 novel gene. HOXB3, SEPT5, ALDH1L2,
HERPUD1, and CDX2 were all downregulated in response to FB1. Of these, CDX2, HOXB3,
IRX3, and FST have been linked to abnormal embryo and brain development, while HERPUD1
and CERT1 have been linked to oxidative stress. These genes are of interest and should be
examined further.
CDX2, HOXB3, and IRX3 are transcription factors that have been characterized in the
developing embryo and involved in neural tube patterning and closure. CDX2 is necessary for
axial elongation (Chawengsaksophak et al., 2004), cell polarity (Savory et al., 2011), and neural
tube closure (Zhao et al., 2014). Interestingly, CDX genes are upstream to HOX genes,
including HOXB3 (Bel-Vialar et al., 2002). HOXB3 is known to regulate hindbrain patterning in
the early embryos (Trainor and Krumlauf, 2000). IRX3 is expressed in neural progenitor cells
(Bellefroid et al., 1998), is associated with neuronal differentiation (Briscoe et al., 2000), and
responsible for forebrain-midbrain boundary formation and patterning (Anselme et al., 2007).
Follistatin (FST) is a BMP-inhibitor expressed throughout early embryo development and
patterning. One study found that when neural cells were exposed to FST, cell fate switched from
a dorsal to a ventral neuronal fate (Liem et al., 2000). FST is also expressed during somite
differentiation in the chick (Amthor et al., 1996).
HERPUD1 is localized to the endoplasmic reticulum (ER) and is upregulated in response
to ER stress (Ho and Chan, 2015). Most research surrounding HERPUD1 has focused on cancer
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Table 4.2: Gene Table for Significant DEGs from Fumonisin vs PBS RNA-seq Library.
Expression of 20 genes was significantly altered in embryos exposed to Fumonisin B1 when
compared to PBS control. Expression of 5 DEG was reduced (above bolded line), while 15
DEGs were overexpressed.
Ensembl Gene ID

Gene
Name

ENSGALG00000034983
ENSGALG00000001220

CDX2
HERPUD1

ENSGALG00000012691

ALDH1L2

ENSGALG00000001688
ENSGALG00000043219

SEPT5
HOXB3

ENSGALG00000005552

PTBP2

ENSGALG00000013061

PAPD7

ENSGALG00000013510

UTP15

ENSGALG00000042045
ENSGALG00000001782

IRX3
PLAA

ENSGALG00000014740
ENSGALG00000015144

IPO11
ZFAND5

ENSGALG00000002227
ENSGALG00000020569

DMXL1
DIMT1

ENSGALG00000014952

CERT1

ENSGALG00000014765
ENSGALG00000038723

TRIM23
RPP25L

ENSGALG00000014908
ENSGALG00000014721
ENSGALG00000006425

FST
Novel
SLC6A6

Gene Product
Caudal type homeobox 2
Homocysteine inducible ER
protein with ubiquitin like
domain 1
Aldehyde dehydrogenase 1
family member L2
Septin 5
Homeobox B3
Polypyrimidine tract binding
protein 2
Poly(A) RNA polymerase D7,
non-canonical
UTP15, small subunit
processome component
iroquois homeobox 3
Phospholipase A2 activating
protein
Importin 11
Zinc finger AN1-type
containing 5
Dmx like 1
DIM1 dimethyladenosine
transferase 1 homolog
Collagen type IV alpha 3
binding protein
Tripartite motif containing 23
Ribonuclease P/MRP 25kDa
subunit-like
Follistatin
MIER family member 3
Solute carrier family 6
member 6
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2-Fold
Change

P-value

Padj

-1.40067
-1.2556

2.26E-05
5.43E-05

0.010818
0.015904

-1.19227

6.8E-05

0.016351

-1.07444
-1.03882

0.000487
0.000426

0.037773
0.035536

1.014625

0.000112

0.022187

1.029224

0.000419

0.035536

1.055511

0.000106

0.022187

1.067911
1.070945

0.000255
0.000627

0.027563
0.043072

1.114409
1.123074

1.06E-05
0.000251

0.010818
0.027563

1.131007
1.182124

4.5E-05
0.000569

0.014469
0.041204

1.188065

0.000259

0.027563

1.200238
1.362105

0.000175
0.000315

0.025554
0.030921

1.519573
1.534165
1.626446

0.000826
6.53E-06
1.09E-13

0.048188
0.010818
7.36E-10

biology and ER stress, with little to no information regarding the role it may play in embryonic
development. CERT1 is a ceramide transporter responsible for trafficking ceramides from the
ER to the Golgi apparatus for glucosylceramide generation (Hanada et al., 2009). Because FB1
is known to reduce ceramide generation, it may be that CERT1 expression is upregulated in
embryos exposed to FB1 as an attempt by the embryo to try and traffic what little ceramide
exists in the ER to the Golgi for necessary modifications and use.
Discussion
RNA-sequencing has greatly impacted our understanding of both normal and abnormal
embryonic growth and development. This study presents a list of novel genes that are
differentially expressed under conditions of toxicants known to induce neural tube defects
(NTDs), the second most common defect in the world.
In this study, five libraries were generated: two control (1xPBS and 0.5% DMSO) and
three treated (100 µM ceramide, 100 µM fumonisin B1, and 600 µM valproic acid). A similar
number of total genes was measured in each treatment library. A Gene Ontology analysis was
performed on each treatment library to categorize genes based on their function within the cell,
showing no significant difference across libraries.
Treatment libraries were compared to their respective controls and differentially
expressed genes (DEGs) were measured, with no significantly affected pathways were identified
for any library. Expression profiles of DEGs identified in the Ceramide vs DMSO library,
revealed 11 genes of interest (GOIs) that were significantly downregulated and 5 GOIs were
significantly upregulated (Table 4.1). Our lab is interested in characterizing and evaluating five
of these genes in the chick embryo to determine whether they play a role in neural tube closure.
These genes include TXNIP, DDIT4, ADNP, CKB, and SLC38A2. The expression of 5 GOIs
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from the Fumonisin vs PBS library were significantly downregulated, with 15 GOIs showing
significant upregulation (Table 4.2). We are interested in elucidating the roles of FB1 regulation
of CDX2, HOXB3, IRX3, UTP15, and FST. Some genes identified here have been previously
linked to neural tube closure, brain patterning, or NTDs, including CDX2, HOXB3, IRX3,
UTP15, and FST. Other genes identified have been associated with oxidative and endoplasmic
reticulum (ER) stress: TXNIP, HERPUD1, and CERT1. For this study, the gene expression
profiles of our three VPA samples differed from each other. This prevented the proper analysis
of VPA significantly altered GOIs, therefore additional samples have been submitted for RNAseq analysis.
The small number of GOIs in this study provides a specific and directed approach to
future studies to characterize expression profiles in the neural tube, both normal and abnormal,
using in situ or immunohistochemistry to determine whether these genes contribute to the
morphological defects resulting from toxicant exposure. Additional studies may examine the
role of ER stress as another means by which C2, FB1, or VPA disrupt normal development.
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CHAPTER 5: Conclusions
The purposes of this research were four-fold: 1) to characterize the effects of C2ceramide (C2), fumonisin b1 (FB1), and valproic acid (VPA) on cellular viability,
differentiation, and oxidative state; 2) evaluate morphological and histological changes in the
developing neural tube of embryos treated with C2, FB1, or VPA; 3) determine whether changes
in the redox state of embryonic tissue were altered under treatment conditions, and whether those
changes are similar or different across treatments; and 4) evaluate and compare gene expression
profiles of embryos treated with C2, FB1, or VPA during neural tube closure.
To address the first specific aim we treated undifferentiated P19 embryonic carcinoma
cells with varying concentrations of C2 (6.25-200 µM), FB1 (0.1-800 µM), and VPA (0.05-2.4
mM) to assess viability (MTT assay) and oxidative stress (DCF assay). This informed our
working concentrations of 100 µM C2, 100 µM FB1, and 600 µM VPA for all future studies. We
then initiated neuronal differentiation in P19 cells and dosed with working concentrations over a
4- day period to assess the effect of each toxicant on cellular differentiation capability. We
demonstrated that C2 had the greatest effects on the cell by both inducing ROS and preventing
differentiation if exposure occurred within the first 2.5 days of differentiation. We also showed
that VPA, while having no effect on ROS production, also reduced cellular capacity to
differentiate with early exposure. However, FB1 did not induce ROS or prohibit differentiation
in the P19 cells. These results indicate that while all three toxicants have the capability of
disrupting neural tube closure, they have unique responses at the cellular level.
In the second specific aim, we exposed chick embryos at the beginning of neural tube
closure (HH8) to each toxicant (100 µM C2, 100 µM FB1, or 600 µM VPA) for 24 h and
assessed the morphological effects. We demonstrated for the first time that C2 exposure during
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neurulation disrupts proper closure, resulting in increased frequency (45%) of NTDs when
compared to control (0.5% DMSO). We confirmed that FB1 and VPA exposure increased the
incidence of NTDs in the chick embryo (50% and 69%, respectively). We evaluated the types of
NTDs, showing that these toxicants replicate human events generating a random number of
cranial, caudal, or cranial + caudal defects in affected embryos. Embryos growth was retarded
significantly in those exposed to FB1; they were significantly smaller and developed fewer
somite pairs over time than untreated embryos. In C2-treated embryos with NTDs, the number
of somite pairs was reduced over the 24 h period. Cellular apoptosis was unaffected in C2- and
FB1- treated embryos but increased with VPA exposure, while proliferation, measured by
evaluating PH3 expression, was reduced across treatments.
For the third specific aim, we measured glutathione (GSH) redox potential (Eh) as an
indicator of cellular and tissue redox state. We treated undifferentiated and neuronally
differentiated P19 cells to 100 µM C2, 100 µM FB1, or 600 µM VPA and collected samples at
various time points (1, 2, 4, 6, 8, 12, or 24 h) to understand how the toxicants were affecting the
redox state over time. Undifferentiated cells were unaffected by C2 and revealed minor
oxidizing shifts in response to VPA or FB1. However, we showed that differentiated cells were
more susceptible to the redox stress of the toxicants. Under VPA exposure, the GSH Eh showed
a significantly oxidizing shift in the cellular redox state. C2 induced oxidation after 12 h of
exposure, while FB1 had no effect. We similarly exposed chick embryos to each toxicant and
collected samples at 1, 2, 4, 8, 12, and 24 h to measure GSH Eh. Three different responses were
observed in the embryos: C2 caused an oxidizing shift in the Eh between 1-8 h after exposure,
FB1 induced the opposite reaction, resulting in a reducing shift between 1-8 h post exposure, and
the GSH Eh showed in initial reducing shift (1 h) followed by an oxidizing shift (4 h) in VPA-
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treated embryos. This is the first time three toxicants known to cause the same defect were
tested in the same animal model and collected for GSH Eh to compare the resulting shifts in
redox state. Because mitochondrial function and oxidative stress are often associated together,
we also examined mitochondrial respiration at 12 h post-treatment for embryos exposed to each
toxicant. We showed that O2 flux was reduced with C2 and FB1 treatment but not VPA. These
data support the concept that an oxidizing or reducing shift in the redox state can lead to protein
modifications, resulting in downstream effects that may alter neural tube closure.
Finally, for specific aim four, we compared the gene expression profiles for embryos
treated with C2, FB1, or VPA to control embryos 6 h after exposure. We chose 6 h because a
shift in the redox state was observed at 1 h in all treatments and resulting changes in gene
expression would likely be observed 4-6 hours after these shifts. Our VPA samples all showed
very different gene expression profiles, as measured by RNA-seq, therefore comparing them to
obtain any significance was impossible. Additional samples are prepped to be sequenced and
will be analyzed upon completion. The data obtained from C2- and FB1-treated embryos
revealed a concise list of 16 and 20 genes, respectively, that were significantly up- or downregulated. Of these genes, we identified 10 genes of interest to evaluate in future studies.
In conclusion, this body of work significantly contributes to our understanding of the
effects of these NTD-inducing toxicants during early embryonic development. For the first time,
C2-ceramide has been reported as a novel inducer of NTDs. The cellular and embryonic GSH Eh
profiles were characterized and have shown for the first time that the three NTD-inducing
toxicants have differential responses in redox state. This novel comparative analysis combines
several descriptive measures to provide evidence of how variable the effects of teratogenic
compounds are on the redox state of a developing embryo.
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